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ABSTRACT 
 
Grzegorz Zapotoczny: Contribution of DNA helicases to genome stability 
(Under the direction of Jeff Sekelsky) 
 
DNA double-strand breaks (DSBs) are one of the most deleterious lesions to the cell. 
Even a single unrepaired DSB can lead to apoptosis, recombination, loss of heterozygosity, and 
cancer, thus it is essential for DSBs to be repaired. Synthesis-dependent strand annealing 
(SDSA) is thought to be a major pathway of DSB repair in mitotically dividing cells, yielding 
non-recombinant products. Assays that directly measure SDSA have been used to study SDSA in 
fruit flies and yeast, however, in humans SDSA is poorly understood and the players involved 
are unknown due to the lack of an SDSA assay. I have developed the first SDSA assay in human 
cells and present the first direct evidence for SDSA in humans. Furthermore, I report here that 
human BLM helicase, unlike its Drosophila ortholog is a negative regulator of SDSA. I 
identified RTEL1 as another negative SDSA regulator. This study provides new insights into the 
molecular basis of SDSA regulation and shows that BLM and RTEL1-deficient cells exhibit 
longer synthesis tracts which facilitates SDSA repair. To complement my studies, I utilized a 
DR-GFP assay to measure GC levels and engineered a crossover-gene conversion (CO-GC) 
assay and demonstrate here that BLM is responsible for suppression of COs in human cells 
despite its inhibitory effect on SDSA.  
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CHAPTER 1 
INTRODUCTION 
 
DNA and Genome Stability 
DNA is the carrier of genetic information, and its integrity is essential for proper 
functioning of all cells. The DNA of all living organisms is prone to damage from both 
exogenous (UV and gamma radiation, chemicals) and endogenous (free radicals and reactive 
oxygen species, stalled or collapsed replication forks) sources. Among of the most dangerous to 
the cells are DNA damaging agents that cause double-strand breaks (DSBs). Even a single DSB 
can lead to cell apoptosis, loss of heterozygosity (LOH) of a tumor suppressor gene, and thus 
eventually to cancer. Therefore, understanding how DSBs are repaired and identifying the 
players involved in this process is of great priority.  
Since the discovery of the DNA double-helix structure by Watson and Crick (Watson and 
Crick, 1953), there has been a tremendous progress in the field of DNA damage repair. Our 
continuous effort to further the knowledge of the very processes that keep us alive and their 
extreme importance has been reemphasized by awarding last year Noble Prize to three great 
scientists: Aziz Sancar, Tomas Lindhal, and Paul Modrich, for their contributions to the DNA 
damage repair field.  
 
DNA Double strand break repair model 
DNA double strand breaks (DSBs) can be repaired via either non-homologous end 
joining (NHEJ) or homology-directed repair (HR) (Symington, 2002). NHEJ is very efficient and 
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cost-effective but can often generate mutations.  HR is thought to be a DSB repair pathway 
assuring fidelity during repair and a cell’s primary choice after DNA replication is complete and 
a sister-chromatid is available as a template for the repair.  
The HR model of double-strand break repair (DSBR), proposed by Jack Szostak, Terry 
Orr-Weaver, and Rodney Rothstein based on their research conducted in Frank Stahl’s 
laboratory in yeast, has been found to be conserved in all diploid organisms studied thus far  
(Fig. 1) (Szostak et al., 1983).  
 
Figure 1.  Model for the DNA DSBs via HR.  
The canonical DSB repair model proposed by Szostak et al (Szostak et al 1983) predicts that the ends of 
DSB (A) are resected (B) to form 3’ overhangs, which then invade homologous template to create a D-
loop and prime synthesis (C). Subsequent DNA ligation leads to a dHJ intermediate formation (D), which 
then can be further processed into CO (E) or NCO (E’) by HJ resolvases. DNA helicases such as BLM 
can act on different repair intermediates to promote NCO formation by supporting NHEJ or SSA (B’) 
SDSA (C’) or dHJ dissolution (D’). See text for details. 
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Upon DSB formation (Fig. 1A) HR orchestrates resection of the DNA 5’ ends so that 
remaining 3’ single-stranded ends (Fig. 1B) can invade the homologous chromosome or sister 
chromatid and use them as templates for synthesis creating a displacement loop (D-loop) (Fig. 
1C). The homology search is one of the least known mechanisms of the DSBR, however, we 
know that Rad51, in humans loaded by BRCA2, is essential (Fig. 1B orange triangles). 
According to this most frequently cited model for HR, further processing generates an 
intermediate with two Holliday junctions (HJs; Fig. 1D). A HJ is a structure of two 
interconnected DNA helices that must be resolved for proper chromosome separation. The HJs 
are cleaved by specialized endonucleases, called resolvases, to generate either a crossover  
(CO; Fig. 1E) or non-crossover (NCO; Fig. 1E’). Either can be associated with gene 
conversions, in which the exchange of genetic material is unidirectional.  
Although HR is considered to be error-free, there are potential hazards involved in its 
execution that must be avoided. In proliferating cells, in particular, COs (reciprocal or 
bidirectional exchanges of genetic material) between homologous chromosomes are not desired 
because they may lead to LOH (LaRocque et al., 2011; Wang et al., 2011)). LOH has been 
implicated in carcinogenesis as a major mechanism that leads to the loss of functional copies of 
tumor suppressor genes (Knudson, 1971; Luo et al., 2000). COs can also lead to chromosome 
rearrangements in cases of ectopic recombination between DNA duplications (Cong et al., 2013).  
Knowing that DSBs are rarely repaired as crossovers in mitotically proliferating cells 
(Andersen and Sekelsky, 2010), a pathway of HR that results in mostly NCOs must be employed 
(Fig. 1B’; 1C’; 1D’). Previous work by us and others led to a model that proposes DSBs in 
mitotic cells are being repaired by SDSA (Fig. 1C’). The SDSA model predicts that DNA 
helicases, such as Bloom helicase (BLM), act to unwind recombination intermediates that lead to 
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COs, thus forcing the break to be repaired as a NCO (Andersen et al., 2011). Testing this model 
has proven to be very challenging before the development of proper tools, namely DSBR assays, 
which allow gaining insights into the repair outcomes and pathway choices in model organisms.    
 
The history of DNA DSBR assays 
Drosophila melanogaster assays 
The first Drosophila DSBR assay was developed in the Engels laboratory in 1991 (Gloor 
et al., 1991). These fruit fly geneticists took advantage of the D. melanogaster genome 
containing DNA transposons, called P-elements, which are mobilized upon introduction of the 
source of an enzyme called transposase. Transposase cuts out the P-element leaving a gap which 
is essentially a form of a DSB. These type of assays are often referred to as “gap repair assays”. 
The biggest advantage of this assays is its simplicity and ability to perform a molecular analysis 
of the repair events. They were able to look at 123 conversion tracts and map them using 
restriction digest and sequencing. Interestingly, even though the average tract length was 1379 
base pair (bp), the longest ones were even a few thousands bases long. Their results indicated an 
existence of an unknown DSBR pathway with a “dissolution” of the recombination intermediate 
before second end capture. Although they never mentioned it, the characteristics of this pathway 
indicate it was likely SDSA.  
A few years later, Engel’s group coined the term SDSA and formulated a model that 
encompasses the experimental observations (Nassif et al., 1994). They were able to demonstrate 
nearly 8 kilo-bases (kb) long DNA synthesis tracts upon P-element excision that came not only 
from a sister chromatid, but also from a homologous but ectopic template. The patterns of repair 
indicated that each terminus of the break acted independently from one another to prime 
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synthesis, yielding two single-stranded overlapping sequences. The two ends would then anneal 
to one another and be further extended to fill in the entire gap. 
It was not until 2003 when the first high throughput, SDSA-specific assay, called P{wa}, 
adapted from Kurkulos and Mount (Kurkulos et al., 1994), was utilized in the Sekelsky 
laboratory (Adams et al., 2003). In this assay, the P{wa} transposon carries a copy of the apricot 
(wa) allele of the white (w) gene, which carries an insertion of a 5-kb copia retrotransposon. The 
copia long terminal repeats (LTR) are about 5-kb from each P element end. During gap repair, 
annealing of both single-stranded DNA ends at the two LTRs results in loss of the copia element. 
This outcome, which is easily distinguished phenotypically from the starting P{wa} transposon 
by the change of the flies’ eyes color, cannot be explained by the canonical DSBR model, so it is 
believed to uniquely identify SDSA repair. Another feature of this assay is the ability to analyze 
molecularly the events that failed to complete SDSA. The synthesis that does not reach LTRs 
yields a hypomorphic or amorphic alleles of white which is exhibited by the presence of yellow 
or white-eyed flies. The ratio between flies with different eye-colors is an excellent indicator of 
the SDSA repair success rate and allows utilizing a reverse genetics approach to determine the 
key players involved in this process. This state of the art SDSA assay was also used to 
demonstrate that the strand invasion and synthesis during SDSA is not a single, static event but 
rather consists of multiple evasions events capable to synthesize across a 14kb long gap (McVey 
et al., 2004a).     
 
Saccharomyces cerevisiae assays 
The first yeast gap repair assay came from the Haber laboratory and involved the repair 
of HO endonuclease-induced DSBs (Pâques et al., 1998). What makes it a gap repair assay is the 
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unique design of the repair template that consists of 375bp-long repeats placed in the middle of 
the sequence homologous to the DSB surrounding area. The greatest strength of the assay is the 
ability to provide different repair templates, whether on a donor plasmid or integrated into the 
genome. Interestingly, the repair efficiency was inversely correlated with the complexity of the 
template and the size of the gap, with genomic templates utilized more efficiently that the ectopic 
ones.  However, the main observation from this study was the existence of incorrect or unfaithful 
copying of the repair template which was exhibited by either contractions or duplications of the 
tandem repeats. Whether by slippage accompanying the synthesis after the second-end capture 
and the dHJ formation, or by random pairing and annealing at the repeats during SDSA, it is 
unclear. This assay, however, provided strong evidence for the existence of an alternate to the 
Szostak’s canonical DSBR pathway. Also, in yeast meiosis, upon tetrad and DNA heteroduplex 
analysis, some recombination events are not easily explained by the DSBR model, but rather 
exhibit features of the SDSA repair (Merker et al., 2003). 
The first SDSA assay in yeast came from the Kusano laboratory (Miura et al., 2012) and 
is, in fact, capable of differentiating between both SDSA and NHEJ events. The assay is 
comprised of a plasmid carrying a ura3 gene with an internal deletion and an I-SceI recognition 
site where the DSB is generated, and two chromosomal templates for the repair that consist of 
either a 3’ or the 5’ ura3 fragment. Functional URA3 gene restoration is contingent upon 
synthesizing genetic information from both of the templates for the total of 458 nucleotides from 
which only 300 nucleotides is overlapping. Successful annealing at the 300-nt overlap is then 
scored as an SDSA event, while the restoration of an intact or disrupted I-SceI sequence is 
recorded as an NHEJ event (precise or imprecise NHEJ respectively). This powerful system 
allows scoring hundreds of repair events and analyzing them molecularly. A putative weakness 
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of this assay, however, is using a plasmid that was not integrated to the genome, meaning it may 
not have been chromatinized. As shown in Drosophila cells, the chromatin context is extremely 
important; DSBR in heterochromatin is tightly regulated to promote HR and prevent NHEJ 
(Chiolo et al., 2011; Ryu et al., 2015).  
 
Mammalian cell assays 
 In mammalian cells, direct-repeat GFP (DR-GFP) assay developed in the Jasin 
laboratory, is one of the most known and utilized tools for probing roles of various proteins in 
DSB repair (Pierce et al., 1999). Although originally designed for mouse cells, DR-GFP was 
adapted to various human cell lines like HEK293 or U2OS (Paliwal et al., 2014). In this assay, 
an upstream GFP gene (SceGFP) is disrupted by insertion of an I-SceI site. A downstream GFP 
fragment (iGFP) serves as a template for repair. Gene conversion replaces the I-SceI site with 
GFP sequences, generating an intact GFP gene. Gene conversion in this assay has been 
interpreted as arising through SDSA (Paliwal et al., 2014), but there are no features that 
distinguish between SDSA and DSBR.  
Another gene conversion assay came from the Scully laboratory and although does not 
look specifically at SDSA, its unique feature is an ability to examine not only the levels of GCs, 
but also whether the synthesis tracts are long of short (Chandramouly et al., 2013). The design is 
similar to the DR-GFP assay, however should the 3’ end extension continue past the GFP gene, 
and use a sister chromatid as a template, a distal end of RFP is copied and a red fluorescence is 
gained. This allows simultaneously screening for short-tract gene conversions (STGC) and long-
tract gene conversions (LTGC).   
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Xu et al. developed a novel human cell assay in which gene conversion could be detected 
simultaneously at the DSB site and at another site about one kilobase pair (kb) away (Xu et al., 
2012). They found that the two were often independent and concluded that SDSA is a major 
mechanism for DSB repair in human cells, but they could not exclude DSBR as a possible 
source. 
Development of the CRISPR/Cas9 system for genome engineering (Cong et al., 2013; 
Mali et al., 2013) opened up new possibilities in terms of introducing DSBs and creating DSBR 
assays. It is suggested, replacement of multi-kilobase fragments after Cas9 cleavage most likely 
occurs through SDSA (Byrne et al., 2015), but this has not been directly tested. Although it is 
speculated, there is no direct evidence confirming SDSA existence in human cells, as no human 
SDSA assays have been developed just yet.  
 
Features of an ideal DSBR assay 
 Just as DSBR is essential for genome stability and proper maintenance, clarity of DSBR 
assays is essential for their proper interpretation. One of the biggest issues of the human assays 
utilized to study DSBR outcomes to date is their ambiguity in determining the exact DSB’s fate.  
An ideal DSBR assay would be capable of differentiating between SDSA and other HR 
repair outcomes such as COs or GCs associated with dHJ resolution or dissolution. Another 
important feature is the ability to analyze repair events on a molecular level either by sequencing 
or PCR-based methods. Whole organism assays provide more physiological conditions, 
however, cell-based assays allow for higher reproducibility and an analysis of hundreds of 
thousands events, if not millions. Standardized and automatized systems, especially if they 
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utilize a presence of fluorescent markers and flow cytometry, will surpass the naked eye and 
subjectivity during data collection.  
With an increasing understanding of epigenetics, the importance of DNA and histone 
modifications, in determining the DNA’s accessibility to repair machinery, it is evident 
chromosomal assays provide more accurate insights into repair mechanisms than the plasmid-
based ones. Multiple repair templates, especially if containing single-nucleotide polymorphisms 
(SNPs) to identify the source of the DNA sequence, provide more mechanistic details than other 
assays that cannot determine whether one or both DSB ends are involved in the homology search 
and priming DNA synthesis. Last but not least, DSB itself and how it is generated is of great 
importance. P-element excision rate is low but engineering a repair template is not needed as the 
intact sister-chromatid is always available in post-replication cells. Adenoviral-delivered I-SceI, 
which has an 18nt long recognition sequence normally absent in the human genome, is not only 
very specific but also effective with up to 85% cutting efficiency as measured in HEK293 cells 
(Anglana and Bacchetti, 1999). High cutting efficiently for endonucleases is vital as uncut I-SceI 
and the product of precise NHEJ are indistinguishable. Processing of the Cas9-generated DSBs is 
still poorly understood, but it is conceivable to think DNA blunt ends created this way might 
undergo a different type of processing than DSBs composed of 3’ or 5’ overhangs.  
All of these features are crucial for accurate data interpretation, especially when trying to 
compare the results in the backgrounds deficient or devoid of DSBR candidate proteins. DNA 
helicases, for instance, have been implicated in many processes pertaining to DNA repair and 
replication but their exactly role in human cells has been elusive due to the lack of precise assays 
to study them.    
 
    
 
10
DNA helicases involved in DSBR repair 
  
 DNA helicases is a group of evolutionarily conserved enzymes utilizing energy from 
ATP hydrolysis to traverse across a double-stranded DNA molecule breaking hydrogen bonds 
between nucleotides in the process. Helicases recognize specific DNA structures, like HJs or D-
loops, and bind single-stranded DNA. Depending on the type, helicases can travel either in the 
3’→5’ or 5’→3’ direction to migrate or disassemble recognized DNA structures (van Brabant et 
al., 2000; Wu and Hickson, 2006). The vast majority of helicases belong to two superfamilies, 
SF1 and SF2. Their classification into families is based on the sequence of the helicase domain 
core (Fairman-Williams, 2010). DNA helicases implicated in DNA damage repair (Table 1) are 
members of a few families and the most of the mechanistic data about them derive from yeast. 
There are ongoing efforts to characterize human, and other model organisms’ orthologs.  
 
SF1: UvrD/ Rep family 
 S. cerevisiae Srs2 and human FBH1 are the two most studied members of this family. 
Srs2 is a 3’→5’ helicase (Rong and Klein, 1993) and is structurally related to bacterial UvrD 
(Veaute, 2005). Copious evidence points out anti-crossover properties of Srs2 (Dervins, 2006; 
Ira et al., 2003) and its ability to negatively regulate HR via Rad51 nucleofilament disruption 
(Krejci, 2003; Veaute et al., 2003). Srs2 mutants exhibit a hyper-recombination phenotype 
(Rong, 1991), and a four-fold decrease in SDSA levels (Miura et al., 2012). Furthermore, Srs2 is 
important in avoiding LOH by promoting NCOs during HR (Miura, 2013).  
 Human FBH1 is also a 3’→5’ helicase, however it is especially unique as it possesses an 
F-box motif that confers ubiquitin ligase activity (Kim, 2004). One of the FBH1 targets is Rad51 
(Chu, 2015). FBH1 promotes an assembly of polyubiquitin chains on RAD51 that lead to its 
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inactivation which is thought to prevent unscheduled recombination at stalled DNA replication 
forks (Chu et al., 2015). Interestingly, expressing hFBH1 in srs2 mutants rescues their viability 
in response to DNA damage, making hFBH1 a mammalian functional analog of Srs2 (Chiolo et 
al., 2007). 
 
SF2: Rad3 family 
 RTEL1 is one of a few members of Rad3 family and its role in DSBR is largely 
unknown, likely because RTEL1 mutations are embryonic lethal in mice (Ding, 2004) and fruit 
flies (Morris et al, unpublished data). RTEL1-deficient ES cells exhibit decreased telomere 
length and proliferative capacity (Ding, 2004). Depletion of RTEL1 in HeLa cells causes four-
fold increase in the frequency of HR. Additionally, the cells become sensitive to mitomycin C, 
but not to IR (Barber et al., 2008). Although RTEL1 was initially identified as a telomere length 
regulator and is responsible for T-loop disruption (Sarek et al., 2015), biochemical studies 
indicate RTEL1can facilitate D-loop disassembly in vitro (Youds et al., 2010), thus could be an 
SDSA regulator. Furthermore, patients suffering from Dyskeratosis Congenita have been found 
to harbor RTEL1 mutations (Savage and Alter, 2009). 
 
SF2: RecQ family 
 There is only one RecQ helicase in yeast, Sgs1, but five in humans: BLM, WRN, 
RECQL1, RECQL4, and RECQL5. Mutations in BLM, WRN, and RECQL4 are responsible for 
Bloom (Ellis et al., 1995), Werner (Yu et al., 1996), and Rothmund-Thomson (Kitato, 1999) 
syndromes respectively. Cells derived from the Bloom Syndrome patients exhibit high-levels of 
sister chromatid exchanges (SCE), which is a hallmark of recombination (Chaganti et al., 1974; 
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Wechsler et al., 2011). WRN and RECQL4 deficiencies do not cause SCE phenotype, but 
RECQL5 knockdown in mouse cells does; intriguingly, it has an additive effect when combined 
with siBLM treatment (Hu et al., 2005). Despite the similarity between BLM and RECQL5 in 
terms of SCE elevation phenotype, when these two helicases are knocked down in HEK293 and 
U2OS cells containing a DRGPF assay construct, siRECQ5 decreases GC levels while the 
siBLM unexpectedly increases GCs (Paliwal et al., 2014).   
BLM helicase has multiple interacting partners and can act at various steps during HR. 
Exo-1, which is a 5’→3’ dsDNA exonuclease, has been found to interact with BLM to resect 
DNA and initiate DSBR (Nimonkar et al., 2008). From all human RecQ helicases tested, only 
BLM was found to stimulate Exo-1resection activity, which would make BLM helicase a pro-
recombination protein. At the same time BLM, and its yeast homolog Sgs1, can disrupt D-loops 
in vitro (Bachrati et al., 2006), promote SDSA in D. melanogaster (Adams et al., 2003; McVey 
et al., 2004a) and, in a complex with Topoisomerase 3 alpha, RMI1, and RMI2, catalyze dHJ 
dissolution (Singh et al., 2008; Wu and Hickson, 2003, 2006), emphasizing BLM’s anti-
crossover roles.  
SGS1 was identified in a genetic screen for the suppressors of the top3 slow growth 
phenotype (Gangloff et al., 1994). The sgs1 phenotypes include slow growth, hyper 
recombination, and chromosome missegregation (Watt et al., 1996; Watt et al., 1995). 
Additionally, Sgs1 is required for non-crossover recombination in budding yeast meiosis (De 
Muyt et al., 2012). 
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SF2: Rig1-like family 
 Fanconi Anemia (FA) is a disorder caused by mutations in one of thirteen FA proteins 
which include FANCM helicase (yeast Mph1), but also BRCA1 and BRCA2 proteins. FA 
patients which exhibit high levels of chromosome instability, are susceptible to cancer, 
hypersensitive to interstrand-crosslinking agents such as mitomycin C (anti-cancer treatment 
drug), and have an increased chance of bone marrow failure (D’Andrea and Grompe, 2003; 
Huang et al., 2010; Meetei et al., 2005; Moldovan, 2009; Wang, 2007). The Drosophila FANCM 
just like BLM is found to promote SDSA (Kuo et al., 2014) and can disrupt D-loops in vitro 
(Romero et al., 2016). The Arabidopsis FANCM and RECQ4 have been found to promote non-
crossover recombination during meiosis, possibly via SDSA (Crismani et al., 2012; Seguela-
Arnaud et al., 2015). Likewise, in Schizosaccharomyces pombe during meiosis, Fml1, the 
ortholog of FANCM/Mhp1, was suggested to promote SDSA (Lorenz et al., 2012; Sun et al., 
2008). Furthermore, the heteroduplex DNA analysis in yeast, that allows to differentiate between 
NCOs coming from SDSA or dHJ resolution, indicates that all three major yeast helicases, Sgs1, 
Srs2, and Mph1, are involved in promoting SDSA (Mitchel et al., 2013). The function of human 
orthologs of the aforementioned helicases in SDSA still remains to be elucidated. 
Table 1. Helicase families and their selected members across species. 
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Scope of this work 
I conducted the work described in this dissertation to develop new tools to study DNA 
double-strand break repair in human cells, and investigate the role of DNA helicases in 
maintaining genome stability. First, I constructed and stably integrated an SDSA assay into 
human U2OS and HeLa cells. When I established that human cells utilize SDSA to repair DSBs, 
I used an siRNA approach to test various helicases for their SDSA regulation ability. I showed 
that BLM and RTEL1 are negative SDSA regulators, and performed a molecular analysis of the 
repair events when either of these helicases were depleted (Chapter 2). Furthermore, I used the 
DR-GFP assay developed in the Jason laboratory to find helicases involved in GC regulation 
(Chapter 3), and based on its design, I created another assay to look at the crossovers and gene 
conversions levels in human cells. Using the CO-GC assay, I was able to show that human BLM 
and FANCM helicases act to downregulate COs in mitotically diving cells (Chapter 3). Finally, I 
discuss all the results, propose a model for the roles BLM and RTEL1 in DSBR, present future 
experimental ideas, and outline suggestions to further improve our assays (Chapter 4).  
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1 
CHAPTER 2 
SYNTHESIS-DEPENDENT STRAND ANNEALING IN HUMAN CELLS 
 
Introduction 
Exactly 40 years ago, Michael Resnick proposed a theoretical model of the DNA double-
strand break repair (DSBR) that involved a heteroduplex DNA (hDNA) intermediate leading to a 
non-reciprocal recombination (in other words: gene conversion-GC or non-crossover-NCO) 
(Resnick, 1976). In theory, after the initial 5’→3’ resection of the double-strand break (DSB) 
ends, the remaining 3’ end can invade a homologous chromosome and initiate synthesis, only to 
be soon unwound and reannealed to the other side of the DSB. It took nearly 20 years to prove, 
and name, this purely speculative model demonstrating DSBR, was indeed utilized by eukaryotic 
cells (Gloor et al., 1991; Nassif et al., 1994). Today, we know this model as synthesis-dependent 
strand annealing (SDSA) which is thought as a predominant pathway of DSBR in mitotically 
dividing cells preventing chromosomal rearrangements, loss of heterozygosity (LOH), and 
cancer (Bignon, 2004).  
One of the greatest challenges of studying SDSA is that how the final product, a gene 
conversion (GC) or non-crossover (NCO), is indistinguishable from the final product of three 
other DSBR processes. Single-strand annealing (SSA), or synthesis-independent strand 
annealing, is thought to occur when a DSB is generated between two repeated sequences with 
long enough homology to facilitate annealing (Paliwal et al., 2014; Wang et al., 2011). SSA 
generates NCOs, but the byproduct of SSA is a deletion encompassing the sequence between the 
    
 
16
two repeats. There are assays designed specifically to study SSA which contain a selectable 
marker placed within the to-be-deleted sequence (Paliwal et al., 2014; Wang et al., 2011). 
Szostak’s model for DSBR predicts that a dHJ can be resolved into CO and NCO products 
(Szostak et al., 1983). NCOs also arise from dHJ dissolution as a product of BTR complex 
(BLM, Topoisomerase 3 alpha, RMI1, and RMI2) (Singh et al., 2008; Wu and Hickson, 2003, 
2006). hDNA analysis can differentiate between NCOs coming from a dHJ intermediate (dHJ 
dissolution and resolution), and those coming from a D-loop disruption (SDSA). dHJ dissolution 
yields NCOs with hDNA on both sides of the gap, while dHJ resolution - in both cleavage 
products, but SDSA yields hDNA only on one side of the gap (Mitchel et al., 2013). 
Furthermore, Allers and Lichten demonstrated, at least during yeast meiosis, there is a 
differential timing and control of NCO and CO recombination (Allers and Lichten, 2001). COs 
and NCO that come from a dHJ intermediate appear later than NCOs coming from an 
intermediate preceding dHJ (presumably via SDSA).  
To date, there are only two SDSA assays, one in Drosophila named P{wa} (Adams et al., 
2003), the other in S. cerevisiae (Miura et al., 2012). Both of the assays present unique, but 
different solutions to the SDSA identification dilemma. In the Drosophila SDSA assay, excising 
the copia P-element within a white gene (hypomorphic apricot allele) creates a gap that can be 
repaired either via SDSA or HR with a dHJ as an intermediate; SSA is not an option as there are 
no repeated sequences in the vicinity of the break. The repair template is an intact sister 
chromatid and thus, both dHJ dissolution and resolution yield products that are indistinguishable 
from the initial sequence hence the flies maintain their apricot eye color phenotype. SDSA and 
SDSA alone can facilitate annealing at the copia long terminal repeat (LTR) sequence within the 
white gene resulting in the restoration of the wild type white gene; the flies exhibit a red eye 
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color phenotype. DSBR via end-joining in this assay results in a loss of a functional white gene 
hence the flies exhibit a white eye color phenotype. In the yeast SDSA assay, the I-SceI-
generated DSB in a nonfunctional plasmid DNA ura3 gene, cannot be repaired via dHJ-mediated 
pathways as the templates for the repair reside on two different chromosomes and the 
recombination between them would lead to lethal chromosomal rearrangements. SDSA and 
NHEJ are the only repair products retrievable in this assay, and only SDSA leads to the 
restoration of the functional URA3 gene/5-FOA sensitivity. 
 
Results 
Human U2OS cells repair DSBs via SDSA  
SDSA is thought to be a major pathway preventing COs and leading to NCO products. 
However, there is no direct evidence indicating that human cells utilize SDSA to repair DSBs. 
To assess the existence of SDSA in humans, I developed the first human SDSA assay (Fig. 2).  
The SDSA assay has an mCherry gene in which a 350-bp segment was replaced with the 18 bp  
I-SceI recognition sequence, rendering the gene non-functional (Fig. 2A). Expression of I-SceI 
enzyme generates a DSB (Fig. 2B). A split template for repair by HR is located downstream. 
Each half has 800 bp of homology adjacent to the break site plus the 350 bp of deleted mCherry 
sequence; these are separated by a 3-kb spacer of unique sequence (Fig. 2A). Since the 350-bp 
sequence is on both sides of the spacer, it constitutes a direct repeat similar to the copia LTRs of 
P{wa}. Each end of the I-SceI-induced break can invade the half of the template to which it is 
homologous, either simultaneously or sequentially (Fig. 2C). If synthesis on each side extends 
past the 350 bp repeat before the nascent strands are dissociated from the template, these regions 
can anneal to one another (Fig. 2D).  
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Figure 2.  Human U2OS cancer cells undergo DSBR via SDSA.  
(A) Human SDSA assay construct consisting of two mCherry halves (pink) interrupted but either I-SceI 
recognition sequence (White letter “I” on a blue background replacing 350bp sequence of the mCherry 
gene), or a Copia element (yellow); (B) I-SceI endonuclease recognizes a specific sequence and cuts the 
DNA creating a DSB; (C) 3’ ends of the processed DSB invade the repair template priming synthesis; (D) 
disrupted synthesis that amplified 350nt long mCherry repeat leads to the annealing of the extended 3’ 
ends; (E) a functional mCherry gene is restored and the cells that underwent SDSA repair are visible 
under the confocal microscope (Olympus FV1200; 60x objective) (I); (F) NHEJ can repair DSB by 
ligating the two ends of the break together yielding a non-functional mCherry gene; (G) Disrupted SDSA 
followed by end-joining can lead to a partial synthesis and incorporation of the Copia element into the 
upstream mCherry yielding a non-functional mCherry gene; (H) Long and uninterrupted SDSA can lead 
to copying of the homologous template in place of I-SceI sequence yielding a non-functional mCherry 
gene. 
 
Completion of SDSA (removal of any sequences extending into the spacer, filling in of gaps, and 
ligation) restores a functional mCherry gene at the upstream location (Fig. 2E). Sequential one-
ended SDSA is also possible. If one end of the break invades the downstream template, is 
extended by repair synthesis, and then is dissociated from the template, the nascent strand will 
not be complementary to the other resected end; however, this nascent strand will be able to 
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engage with the other half of the repair template based on the 350-bp repeat to initiate a second 
cycle of strand exchange and repair synthesis, leading to the addition of sequences 
complementary to the other resected DSB end. This would also restore a functional mCherry 
gene by SDSA. A functional mCherry gene might also be generated through a combination of 
SDSA and DSBR. In the sequential SDSA scenario described above, the second strand exchange 
event could be processed into a dHJ. The product of dissolution or non-crossover resolution of 
such a dHJ will be identical to that of SDSA; however, if the dHJ is resolved as a crossover, 
generation of a functional mCherry gene it will be accompanied by a deletion of all sequences 
between the upstream mCherry and the downstream template. Dissolution or non-crossover dHJ 
resolution in this scenario cannot be distinguished from SDSA, but formation of such a dHJ 
intermediate does require at least one cycle of D-loop disassembly, a key step that distinguishes 
SDSA from DSBR. 
Other types of repair that do not generate a functional mCherry are also possible (Fig. 
2F-H). A dHJ can be generated if synthesis extends through one mCherry 350-bp repeat, the 
entire spacer, and the other 350-bp repeat. Processing of this dHJ would give a product in which 
the entire template, including the duplicated 350-bp sequences and the spacer, was copied into 
the upstream mCherry gene (Fig 2H). Dissolution or non-crossover resolution would result in 
two copies of the template, whereas crossover resolution would delete intervening sequences 
(Fig. 2A neoR). Non-homologous end joining (NHEJ) can restore or disrupt the I-SceI 
recognition sequence, depending on whether it is precise or imprecise (Fig. 2F). Hybrid repair, in 
which repair is initiated by HR but completed by end joining instead of annealing, can give rise 
to an mCherry in which the 350-bp gap is not completely filled or, if synthesis extends into the 
spacer, with part of the spacer is copied into the upstream mCherry gene (Fig. 2G). SSA repair 
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would lead to a deletion of the sequence between the I-SceI and the proximal mCherry repeat, 
but will not lead to the restoration of the functional mCherry gene. SSA between the upstream 
mCherry and the distal mCherry repeat is impossible as there is no sequence overlap between 
these two DNA sequences. 
To generate cell lines with the SDSA assay construct, I transfected U2OS cells with 
linearized pSDSA vector and used neomycin to select stably-integrated lines. To induce DSBs, I 
infected cells with an adenovirus expressing I-SceI (Anglana and Bacchetti, 1999). I detected 
mCherry activity by fluorescence microscopy (Fig. 2I) as early as two days after viral infection. 
Stable expression persisted through months of cell culturing. Initial molecular analysis of 
genomic DNA from clones derived from single mCherry-positive cells confirmed the absence of 
the I-SceI, restoration of a complete mCherry gene (Fig. 3A). In contrast, the molecular analysis 
of genomic DNA from mCherry-negative clones confirmed the presence of the I-SceI, by both 
PCR and restriction digest (Fig. 3B).  
Figure 3.  mCherry-positive clones are resistant to I-SceI cutting while the mCherry-negative clones 
are susceptible.  
Two images of 1.5% agarose gels with a PCR product using nhei_F and hindiii_R primers (see Materials 
and Methods). (A) Two different mCherry-positive clones were tested using a PCR for the presence of 
functional mCherry gene fluorescence (expected PCR product size: 783bp). As indicated, the clones were 
I-SceI resistant. (B) Two different mCherry-negative clones were tested using a PCR for the absence of 
the 350bp mCherry sequence that restores mCherry fluorescence (expected PCR product size: 433bp. As 
indicated, the clones were I-SceI sensitive. 
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BLM and RTEL1 helicases are negative regulators of SDSA 
The SDSA assay design allows high throughput data analysis using flow cytometry based 
on the cell size and fluorescence. Because U2OS cells adhere to the surface of the well, obtaining 
a single-cell suspension using trypsin-EDTA prior to analysis is necessary (see materials and 
methods). During harvesting a number of cell dies or is still attached to their neighbors despite 
the treatment. Gating strategy (Fig. 4) facilitates cell debris and doublet discrimination to score 
single mCherry-positive cells exclusively. 
 
Figure 4.  Flow cytometry facilitates analysis of SDSA events by detecting mCherry-positive cells.  
A representative siNT scatter plot shown. Forward and side scatter plots (FSC and SSC) allow identifying 
nucleated and single cells in a cell suspension (top panels). Cherry-positive cells are identified in the 
mCherry channel upon exposure to a yellow laser (bottom panels). Population hierarchy with 
accompanying statistics facilitates data recording and interpretation (bottom right) 
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BRCA2 is essential for RAD51-mediated strand exchange and thus SDSA (Sharan et al., 
1997). To validate the SDSA assay, I knocked down BRCA2 in the SDSA-U2OS cells which 
yielded 50% reduction in SDSA (Fig. 5A). Residual SDSA in this experiment may have resulted 
from incomplete loss BRCA2 (Fig 5B) 
Figure 5.  BLM and RTEL1 are negative regulators of SDSA in human cells.  
(A) Relative SDSA frequency in SDSA-U2OS cells upon siRNA treatment.  X-axis: different siRNA 
treatments; Y-axis: percent of the cells exhibiting mCherry fluorescence; values: averaged results of 12 
experiments with 41 data points (NT); averaged results of 9 experiments with 31 data points (BLM); 
averaged results of 5 experiments with 20 data points (RTEL1); averaged results of 3 experiments with 7 
data points (FANCM and RECQL5); averaged results of 2 experiments with 6 data points (FBXO18 and 
WRN)  error bars: standard deviation; **** p<0.0001 
(B)  qPCR analysis of the knockdown efficiency of BLM, BRCA2, FANCM,  and RTEL1 and Western 
blot analysis of a BLM knockdown efficiency. 
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To determine which DNA helicases are involved in SDSA we used a candidate approach 
and selected a panel of genes consisting of: BLM, FANCM, FBXO18, RECQL5, RTEL1, and 
WRN for siRNA knockdown (see materials and methods). These helicases have been either 
previously implicated in DNA DSBR via HR in human cells or identified as positive SDSA 
regulators in model organisms (see introduction).  
Surprisingly, BLM and RTEL1 helicase knockdowns resulted in a nearly two fold increase 
in the SDSA repair as measured by the percentage increase of the number of mCherry-positive 
cells standardized to a non-targeting siRNA control (Fig. 5A). Knocking down FANCM, 
FBXO18, RECQL5, or WRN did not result in a significant change in SDSA. 
 
BLM and RTEL1 are BRCA2-dependent SDSA regulators 
Both BLM and RTEL1 have multiple roles in genome maintenance. BLM, together with 
Dna2, can catalyze extensive DSB end resection, though this function is redundant with Exo1 
(Zhu et al., 2008). BLM with Topoisomerase 3 alpha, RMI1, and RMI2 can catalyze dHJ 
dissolution (Singh et al., 2008; Wu and Hickson, 2003, 2006). RTEL1 was initially identified as 
a telomere length regulator and is responsible for T-loop disruption (Sarek et al., 2015). 
Biochemical studies indicate that RTEL1is responsible for D-loop disassembly, (Youds et al., 
2010), but can unwind DNA secondary structures and promote replication fork progression 
(Vannier, 2013; Vannier and Sarek, 2014) 
To assess whether BLM and RTEL1 act upstream or downstream from the homology 
search step during DSBR to regulate SDSA, I knocked down these helicases in combination with 
BRCA2, which is essential for homology search (Sharan et al., 1997). Consistent with this 
function, we observed a significant decrease in SDSA frequency when BRCA2 was knocked 
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down (Fig. 5A and 6A). When BRCA2 was knocked down simultaneously with BLM or 
RTEL1, decreases of similar magnitude (relative to the increased SDSA frequency of BLM and 
RTEL1 single knockdowns) were observed. I conclude that BLM and RTEL1 impact SDSA 
through functions downstream of strand exchange into a homologous template. 
Figure 6.  BLM and RTEL1 regulate SDSA in a BRCA2-dependent manner.  
(A) Relative SDSA frequency in SDSA-U2OS cells upon siRNA treatment.  X-axis: different siRNA 
treatments; Y-axis: percent of the cells exhibiting mCherry fluorescence; values: averaged results of 5 
experiments (4 for double KDs) with 20 data points per treatment (16 data points per treatment for double 
KDs); error bars: standard deviation;  
(B) qPCR of the knockdown efficiency of BLM, BRCA2, and RTEL1 from one representative 
experiment. 
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Knocking down BLM or RTEL1 results in different repair outcomes  
To further develop our SDSA assay and gain additional insights into the effects of 
knocking down BLM and RTEL, I determined the structures of repair events produced in 
knockdown cells (Fig. 7). I analyzed 55 clones derived from single red-fluorescing cells, 
including 23 from the NT control, 21 from BLM knockdown, ten from FANCM knockdown, and 
one from RTEL1 knockdown. All but one had the structure expected of SDSA (Fig. 2E). The 
remaining clone, which came from non-targeting (NT) siRNA treatment, had lost neoR and the 
template spacer, and therefore may have arisen from SDSA followed by DSBR with crossover 
resolution. These results support our conclusion that cells with restored mCherry utilized SDSA 
to repair the DSB, occasionally coupled with use of DSBR. 
 
Figure 7.  Structures of repair events in cells not expressing mCherry.  
Single cells not expression red fluorescence were grown and then analyzed. (A) The starting construct, 
and the structure found in the majority of clones in each siRNA treatment group. (B) Copying of the 
entire template into the upstream mCherry I-SceI site. (C) Copying of the entire template with loss of 
intervening sequences. (D) Copying of part of the template into the upstream mCherry site. (E) Retention 
of the I-SceI site with loss of the neo and ori sequences. 
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I also analyzed cells that failed to produce mCherry to determine whether some of these 
were produced by other repair processes. In the non-targeting control, all 45 lines examined 
appeared to be identical to the initial construct (Fig. 7A). I titrated the viral concentration to a 
sublethal dose to obtain a maximal possible transfection efficiency, thus these events are likely 
the result of a precise NHEJ. 
The majority of clones from BLM or RTEL1 knockdown cells also had an intact I-SceI 
site; however, structures indicating other repair processes were observed in 11 of 34 clones from 
BLM knockdown (P <0.0001 compared to NT) and 24 of 133 clones from RTEL1 knockdown 
cells (P = 0.0007). In four of BLM knockdown clones and 14 of the RTEL1 knockdown clones 
the entire 3-kb copia spacer sequence was copied from the repair template into the upstream 
mCherry (Fig. 7B and 7C). This extensive repair synthesis might occur through multiple cycles 
of strand exchange, as is believed to occur in Drosophila gap repair by SDSA (McVey et al, 
2004), or through a single, continuous synthesis event. Among the 17 examples in which the 
entire spacer was copied, one from each knockdown sample had lost neoR, a structure that is 
most consistent with a dHJ being resolved to give a crossover (Fig. 7C). The other 15 may have 
arisen by long-tract SDSA or by dissolution or non-crossover resolution of a dHJ (Fig. 7B). 
There were additional repair events from knockdown cells that also had evidence of long-
tract synthesis. Three events from BLM knockdown and seven from RTEL1 knockdown had a 
subset of the spacer copied into the upstream mCherry (Fig. 7D). These are most likely hybrid 
repair that involved long-tract synthesis followed by end joining. There was one event from the 
BLM knockdown that had an intact I-SceI site but had lost neo (Fig. 7E). The source of this 
event and whether it occurred following I-SceI cleavage is unknown. 
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BLM helicase does not alter cell cycle phases   
 Double-strand break repair pathway choice is believed to be dependent on the phase of 
the cell cycle; NHEJ preferred in G1 and HR favored in S/G2/M where a sister chromatid is 
available as a repair template. Detailed studies of the cell cycle progression coupled with DSBR 
assays in human cells indicate that although HR is dominating over S-phase it decreases in G2/M 
(Mao, 2008). NHEJ levels, however, are high throughout the cell cycle with the maximum at 
G2/M. To assess whether BLM helicase knockdown affects the cell cycle and thus could account 
for an increase in SDSA levels, I analyzed cell cycle profiles over the course of three days after 
BLM siRNA treatment and a non-targeting control (Fig. 8). The results indicate that BLM 
knockdown does not affect cell cycle and thus the SDSA increase in BLM-deficient cells is due 
to the BLM processing recombination intermediates rather than a chance in cell cycle phases.  
 
Figure 8.  BLM helicase does not regulate the cell cycle phases.  
Flow cytometry analysis of the cell cycle progression upon siRNA treatment in U2OS-SDSA cells. Flow 
cytometry graph representing DNA content upon propidium iodine staining in (A) NT siRNA Day 3 and 
(B) BLM siRNA Day3. (C) A table containing the percentage of cells in each phase of the cell cycle upon 
siRNA treatment measured every day for 3 days as indicated. 
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Small particle ML216, BLM inhibitor, affects SDSA 
 To gain further insights into the function of BLM helicase in SDSA, especially in regards 
of its inhibitory effects on SDSA revealed by the siRNA knockdown, I decided to test the effects 
of ML216 on the DSBR repair in U2OS-SDSA cells. ML216 is a small particle discovered in a 
large screen for BLM inhibitors (Nguyen and Hickson, 2013). Molecularly ML216 is a DNA 
mimicking compound with two aromatic rings that prevents BLM helicase from interacting with 
DNA. The authors of the paper characterized ML216 thoroughly using both biochemical and 
genetic approaches. 50 uM concentration of ML216 inhibits DNA binding and the helicase 
activity of both truncated and full-length BLM. Gel-based DNA unwinding assays reveled that 
ML216 is inhibiting primarily BLM and at higher doses can also inhibit WRN helicase, but no 
inhibition was discovered for other RecQ helicases like RecQL1, RecQL5, and URVD. BLM 
deficient cells exhibit high levels of SCEs (Wechsler et al., 2011) ML216 mimics this phenotype 
but to a lesser degree, however, it does not exacerbate the elevated SCE phenotype in the cells 
already devoid of BLM (Nguyen and Hickson, 2013). To assess the influence of ML216 on 
SDSA in human cells, I treated the cells with the inhibitor at the same time when I-SceI-
expressing virus was added. Surprisingly, ML216 treatment leads to a two-fold reduction of 
SDSA frequency (Fig 9A) as oppose to a two-fold increase of SDSA in BLM siRNA knockdown 
(Fig 5A).  
The striking contrast between ML216 and BLM siRNA phenotypes indicates that ML216 
might have other, yet unknown, targets in the cell that are necessary for SDSA, or that ML216-
bound and deactivated BLM is now binding and sequestering other DSB repair proteins 
preventing them from executing SDSA. To parse out which of these two aforementioned effects 
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ML216 might have on the cell, I designed an experiment in which the cells are transfected with 
BLM siRNA prior to ML216 treatment. If ML216 acts on BLM helicase then knocking down 
BLM should render ML216 ineffective and thus SDSA levels will go up. However, if ML216 
has a different target, then the ML216 phenotype will supersede the one of BLMs, and the SDSA 
levels will go down. The data of the ML216 treatment in conjunction with the siRNA 
transfection (Fig. 9B) indicate that ML216 is likely targeting a different DNA DSBR protein 
target other than BLM helicase as the SDSA levels are reduced even in the cells treated with 
BLM siRNA. It is worth noting that, although ML216 can inhibit WRN helicase, there must be 
other ML216 targets in the cell affecting SDSA since WRN knockdown does not affect SDSA 
(Fig 5A). 
 
 
 
Figure 9.  BLM inhibitor, ML216, influences SDSA. 
(A) Relative SDSA frequency in SDSA-U2OS cells upon ML216 treatment.  X-axis: different drug 
treatments; Y-axis: percent of the cells exhibiting mCherry fluorescence; values: averaged results of 5 
experiments with 14 data points per treatment; error bars: standard deviation; significance: ML216 
vs.DMSO: ****;  p< 0.0001. 
(B) Relative SDSA frequency in SDSA-U2OS cells upon ML216 and siRNA treatment.  X-axis: different 
drug and siRNA treatments; Y-axis: percent of the cells exhibiting mCherry fluorescence; values: 
averaged results of 3 experiments with 8 data points per treatment (DMSO-siNT and ML216-siNT) and 1 
experiment with 4 data points (DMSO-siBLM and ML216-siBLM); error bars: standard deviation. 
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BLM helicase is a negative SDSA regulator in HeLa cells  
 To complement the research I have conducted in U2OS and to investigate whether SDSA 
regulation is specific to U2OS or universal across all human cell, I repeated some of the 
aforementioned experiments in HeLa cells. First, I stably integrated linearized pSDSA into HeLa 
cells and upon infection with the I-SceI- expressing virus, I observed mCherry positive cells 
under the fluorescent microscope (Fig. 10A). Then, I tested the consequences of BLM 
knockdown for SDSA regulation (Fig. 10B). BLM helicase in HeLa cells, just like in U2OS, is a 
negative SDSA regulator, indicating that the roles of DNA helicases in all human cells are 
conserved. 
 
Figure 10.  BLM helicase is a negative SDSA regulator in HeLa cells.   
(A) Fluorescence microscopy image of mCherry positive HeLa cells. (B) Relative SDSA frequency in 
SDSA-HeLa cells upon siRNA treatment.  X-axis: different siRNA treatments; Y-axis: percent of the 
cells exhibiting mCherry fluorescence; values: averaged results of 3 experiments with 4 data points per 
treatment; error bars: standard deviation; significance: NT vs. BLM: ** p=0.0017. 
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Conclusion 
In conclusion, I showed that human cells, as hypothesized, can utilize SDSA to repair 
DSBs. I developed the first human cell SDSA assay, which is a tool designed specifically to 
detect SDSA in human cells by following mCherry fluorescence using flow cytometry  
(Fig. 2 and Fig. 4). I also identified two helicases, BLM and RTEL1, which are SDSA regulators 
in human cells (Fig. 5). Unlike our initial hypothesis based on the results derived from yeast and 
fruit flies, BLM and RTEL1 do not promote SDSA, but rather are its negative regulators, which I 
demonstrated by utilizing an siRNA knockdown approach targeting various helicases (Fig 5). I 
observed a nearly two fold increase (on average from 1.4% to 2.4%) in SDSA efficiency in the 
cells devoid of BLM or RTEL1 (Fig 5). I also determined that these helicases, despite their 
multiple functions in the DSBR pathway and in the cell, act in a BRCA2-dependent manner  
(Fig. 6), which means that the SDSA regulation occurs post the homology search step in the 
DSBR model (Fig 1). 
To further investigate the contribution of BLM and RTEL1 to double-strand break repair, 
I analyzed single-cell derived colonies of the siRNA treated repair events at the molecular level 
(Fig 2 and Fig. 7).  All mCherry positive clones are SDSA events as determined by sequencing 
and resistance to I-SceI cutting (Fig. 2). mCherry negative clones from the BLM and RTEL1 
siRNA treated cells exhibit various repair patterns (Fig. 7) indicating that they can be a result of 
SDSA, DSBR with dHJ resolution or dissolution, NHEJ, or a combination of the above; SDSA 
followed by DSBR or end-joining. 
Comprehensive molecular analysis indicates that the synthesis-tract length is extended in 
the helicase-deficient background which can account for observed SDSA increase. Regardless, I 
explored other possibilities in attempt to investigate the increased SDSA phenotype in siBLM 
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samples. I conducted a series of SDSA assay experiments using BLM inhibitor – ML216, which 
unexpectedly revealed that ML216 treatment decreases SDSA efficiency in a BLM-independent 
manner indicating that ML216 has another target in the cell. (Fig. 8). Lastly, I performed a 
detailed cell cycle analysis to reveal whether BLM helicase extends S-phase and thus promotes 
HR, but I did not find any evidence to support it. 
Together, the data from Chapter 2 confirm that SDSA is a major pathway of DSBR in 
human cells and that DNA helicases, such as BLM and RTEL1, regulate it. DNA helicases are 
also thought to inhibit hyper-recombination by limiting the number of COs in mitotically 
dividing cells. A dramatic increase in HR in the cells with reduced BLM or RTEL1 levels 
supports that notion. To attempt answering questions regarding the contribution of DNA 
helicases to CO regulation, I designed a fluorescence based CO-GC assay. The experimental 
approached successfully utilized in Chapter two has been instrumental in learning about SDSA 
in human cells. I used a similar approach when looking at COs and GCs in human cells, which I 
discuss in Chapter 3. 
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Materials and Methods 
Construction of assay plasmids  
The SDSA assay construct was based on pEF1a-mCherry-C1 vector (Clonetech #631972). 
A fragment of mCherry was removed by cutting with NheI and HindIII and inserting annealed 
oligonucleotides containing an I-SceI recognition sequence and a part of the mCherry sequence. 
The product, pEF1a-mCherry-I, had 350 bp of mCherry deleted and the I-SceI sequence inserted. 
In parallel, 5’ and 3’ mCherry fragments, overlapping by 350 bp, were PCR-amplified and 
cloned into a vector containing a fragment of the copia retrotransposon from D. melanogaster. A 
fragment of HPRT was cloned out of the DR-GFP construct. This entire module (5’ mCherry – 
copia – 3’ mCherry – HPRT) was PCR-amplified and cloned into the pEF1a-mCherry-I to 
produce pSDSA. 
 
Generation of stably transfected cell lines  
U2OS and HeLa cells were cultured under normal conditions (DMEM +10% FBS + 
pen/strep) for 24h till they reached 80% confluency before transfection with the SDSA assay 
constructs using a Nucleofector™ 2b Device (Lonza #AAB-1001) and Cell Line Nucleofector® 
Kit V (Lonza #VCA-1003). One week post-transfection appropriate antibiotics were added to 
select for the cells with a stably-integrated construct. The SDSA assay construct contains a neoR 
gene; cells receiving this construct were treated with 700 μg/ml G418 (Sigma # A1720) for one 
week and then a single-cell clones were derived. 
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DNA repair assay and flow cytometry 
SDSA-U2OS cells were cultured in 10 cm dishes containing 10 ml of DMEM medium 
with high glucose; Corning) until split onto 6-well plates at a concentration of 5x104 cells per 
milliliter using 0.05% Trypsin 0.53% mM EDTA solution (Corning). Upon reaching ~60% 
confluency, the cell were treated with an siRNA reaction mixture (90 nmol of siRNA and 8 μl 
lipofectamine 2000 reagent per well; Invitrogen). 24 hours after transfection the siRNA reaction 
mixture was replaced with the fresh culture medium. 12 hours later the cells were treated with 
100 μl of I-SceI-expressing adenovirus (Anglana and Bacchetti, 1999) (previously titrated to a 
non-lethal concentration). After another 24 hours the medium was replaced and thus the 
adenovirus removed. 72 hours later the cells were harvested and resuspended in 1x PBS 
(Corning) supplemented with 2% fetal bovine serum (FBS) and 5 mM EDTA for flow cytometry 
acquisition on a BD LSRFortessa, using 488nm and 561nm lasers to detect the mCherry 
fluorescence. 
 
Genomic DNA isolation 
Cells were cultured in a 15 cm dish till they reached 100% confluency. Then they were 
rinsed gently with 1x PBS and harvested using 0.05% Trypsin 0.53 mM EDTA and pelleted by 
centrifuging for three minutes at 2000 rpm. Cells were washed with PBS and transferred to 1.5ml 
microfuge tubes and spun for 10 sec to re-pellet. PBS was removed and cells were resuspended 
in TSM + 0.5%NP-40 solution (140 mM NaCl; 10 mM Tris-HCl, pH 7.4; 1.5 mM MgCl2), then 
incubated on ice for 2-3 minutes. After pelleting, cells were resuspended in 1 ml nuclei dropping 
buffer (0.075 M NaCl; 0.024 M EDTA, pH 8.0). The suspension was transferred to a 15 ml tubes 
containing 4 ml of nuclei dropping buffer with 1mg of Proteinase K (final Proteinase K 
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concentration = 0.2 mg/ml), and 0.5% of SDS. The cells were lysed overnight at 37°C. The next 
day an equal volume of phenol was added to lysed nuclei and mixed on an orbital shaker for two 
hours followed by a five minute spin at 2000 rpm. The aqueous phase was transferred to a clean 
tube and an equal volume of chloroform was added and the mix was incubated for 30 mins on an 
orbital shaker. After spinning, the aqueous phase was transferred to a new tube and 0.1 volumes 
of 3M sodium acetate was added, followed by one volume of isopropanol. The DNA was 
spooled out using a glass Pasteur pipette and resuspended overnight in 1 ml TE buffer (10 mM 
Tris-HCl, pH 8.0; 1 mM EDTA, pH 8.0). The next day the DNA was precipitated using 0.5 
volumes of 7.5M NH4OAc and two volumes of ethanol. DNA was spooled out and resuspended 
in 0.5ml TE-4 buffer (10mM Tris-HCl, pH 8.0; 0.1mM EDTA, pH 8.0). Samples were stored in 
4°C until analyzed. 
 
PCR analysis of the repair events 
 DNA from the repair events was isolated according to the protocol above and used in a 
PCR reaction to amplify a desired DNA fragment for sequencing or fragment length 
characterization. 1.5ul DNA was added to each PCR mixture containing primer sets according to 
the Table 2, iProof polymerase (BioRad #424264), and a buffer. PCR amplification reaction 
program was 33 cycles of [20s-98°C; 20s-64°C; 20 to 150s-72°C]. The PCR products were run 
on a 1-1.5% agarose gel with EtBr before imaged.    
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Table 2.  PCR primers used in the SDSA assay study and their location 
 
 
 
 
 
 
 
 
 
Western blot of BLM protein siRNA-treated cells 
U2OS cells were transfected using BLM siRNA or NT siRNA (90nmol) and 
lipofectamine 2000 (8 μl; Invitrogen) and harvested on the third day post-transfection using 
0.05% Trypsin 0.53% mM EDTA solution (Corning). After washing with 1x PBS the cells were 
resuspended in a protein sample buffer (Tris-HCl; SDS; glycerol; bromophenol blue; 150mM 
DTT) and boiled. 20 μl of the protein sample was loaded on a 7.5% SDS-PAGE gel and the gel 
was run for 1-2 hours at 100V. Protein was transferred to a PVDF membrane using a wet transfer 
method (1.5 h at 90 V in 4°C). The membrane was blocked in 5% milk PBS solution and 
primer sequence amplicon size [bp]
1. neo_F ggatgaggatcgtttcgcatg
2. neo_R catagaaggcggcggtggaatcg
3. nheI_F cgtgacgctagcgctaccgg 433 if intact I-SceI
4. hindiii_R cgaagcttgagctcgagatc 783 if SDSA
5. pSDSAprom_F ggccaagatctgcacactgg ↓
6. SDSAseq1_R cctcgcagcaaatgctggatc 1298
7. SDSAseq2_R cagagaatcaactggctgac 1498
8. SDSAseq3_R cgtgagagaagctctatggc 1707
9. SDSAseq4_R ctgtgggcctattactccag 2640
10. SDSAseq5_R gtcccacgcgtcgacaaggc 4112
996
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incubated in PBS plus 0.1% Triton-X plus primary antibodies (rabbit anti-BLM [Abcam #2179] 
at 1:2000 and mouse anti-αTubulin [Sigma #T9026] at 1:8000) overnight at 4°C, rocking. The 
membrane was then washed three times in PBS-T solution. HRP-conjugated secondary 
antibodies were added (goat anti-rabbit 1:5000; goal anti-mouse 1:100,000) and the blot was 
incubated for 1 hour at room temperature. The membrane was washed three times in PBS-T 
solution and then incubated in an ECL solution (Thermo Fisher) for chemiluminescence for two 
minutes. The Western blot image was taken using BIO-RAD Molecular Imager (ChemiDoc 
XRS+) or the X-ray film was developed using a developer. 
 
qPCR evaluation of the siRNA knockdown efficiency  
U2OS cells were transfected using desired siRNA (90 nmol) and lipofectamine 2000 (8 
μl; Invitrogen) and harvested on the 3rd day post-transfection using 0.05% Trypsin 0.53% mM 
EDTA solution (Corning). RNA was extracted using a manufacturer’s protocol for ReliaPrep 
RNA Cell Miniprep System (Promega). Purified RNA was used as a template to generate cDNA 
library with QuantiTect Reverse Transcription Kit (Qiagen # 205310). The qPCR mix was 
contained gene-specific DNA primers, cDNA, and QuantiTect SYBR Green PCR kit (Qiagen #A 
204141). Amplification and quantification was conducted on a RealTime PCR machine 
(QuantStudio 6 flex Real Time PCR System). 
 
Cell cycle analysis by DNA content using propidium iodide 
 U2OS-SDSA cells were washed by centrifugation (200 x g, 5 min, 4°C) two times in 
protein-free buffer Phosphate Buffered Saline without Ca+2 or Mg+2 (PBS). The cells were 
resuspended at 2 x 106 cells in 1 ml of ice cold PBS buffer. Cell number will effect staining. 
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Then the cells were vortexed gently, and then the cell suspension was added dropwise to 9 ml of 
70% ethanol in a 15 ml polypropylene centrifuge tube (Falcon® Cat. No. [35]2097). Cell 
precipitation was observed with a microscope to verify minimum cell clumping. The cells were 
stored at 4°C for 12 - 24 hours before the propidium iodide stating. The cells were centrifuged at 
200 x g, 10 min, 4°C, and the pellet resuspended in 3 ml of cold PBS and transferred to Falcon® 
12 X 75 mm (Cat. No. [35]2054) polystyrene tubes for staining Falcon® Cat. No. [35]2235.   
The cell were resuspended in 300 - 500 µl PI/Triton X-100 staining solution: 10 ml of 0. 1 % 
(v/v) Triton X-100 (Sigma) in PBS add 2 mg DNase-free RNase A (Sigma) and 0.40 ml of 500 
µg/ml PI (Roche # 11348639001).  The cells were incubate 37°C for 15 minutes or for 30 min at 
20°C, then stored at 4°C. The data was acquired on a BD LSRFortessa flow cytometer and 
analyzed using ModFit LT version 4.1 by Verity Software House. 
 
Statistical data analysis 
 GraphPad Prism 6 software (version 6.07) was utilized to generate the figures presenting 
the flow cytometry results of the SDSA assay. Prism also provides a statistical data analysis 
platform. The data was analyzed using two statistical tests; one-way ANOVA with a correction 
for multiple comparisons or Student T test if a single comparison was needed.  
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1 
CHAPTER 3 
CROSSOVERS AND GENE CONVERSIONS IN HUMAN CELLS 
 
Introduction 
Over a 100 years ago Thomas Morgan published his work describing chromosomes as 
the units of inheritance and proposed crossovers as a mechanism for unlinking genes and 
generating diversity during reproduction (Morgan et al., 1915). The first experimental evidence 
however, came from the studies conducted by Barbara McClintock on crossing Zea mays and 
analyzing recombinant progeny (Creighton and McClintock, 1931). Over 50 years ago Robin 
Holliday proposed a model in which the main recombination intermediate is a structure of two 
interconnected DNA helices that he called a Holliday junction (HJ) (Holliday, 1964). However, 
according to the most frequently cited model for HR, DSB processing generates not a single but 
double HJ (dHJ) (Szostak et al., 1983), which needs to be cleaved for proper chromosomal 
segregation during cell division. HJs are cleaved by specialized endonucleases, called resolvases, 
to generate either a reciprocal crossover (CO; Fig. 1E) or a noncrossover (NCO; Fig. 1E’). 
Either can be associated with gene conversion, in which the exchange of genetic material is 
unidirectional (Szostak et al., 1983). COs in meiotically dividing cells are programmed and 
desired as they prevent chromosomal non-disjunction that could lead to chromosome number 
alterations like in Down syndrome. Genetic diversity is also a result of dHJ processing into COs. 
In proliferating cells, in particular, crossovers between homologous chromosomes are not desired 
because they may lead to loss of heterozygosity (LOH) (LaRocque et al., 2011; Wang et al., 
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2011) and chromosome rearrangements in cases of ectopic recombination between DNA 
duplications (Liu et al., 2011). LOH has been implicated in carcinogenesis as it leads to the loss 
of functional copies of tumor suppressor genes (Bignon, 2004; Knudson, 1971; Luo et al., 2000). 
Although the high level of SCEs is a cellular hallmark of BLM-deficient cells, crossovers 
between sister chromatids do not explain propensity for mutations and cancer development in 
Bloom syndrome patients (Chaganti et al., 1974; Wechsler et al., 2011). These symptoms can be 
explained however if elevated levels of COs between homologous chromosomes leading to LOH 
are present. Studies of LOH point out to BLM helicase as one of the important players 
preventing recombination (LaRocque et al., 2011). In the S/P assay developed by Jeannine 
LaRocque in ES cells, LOH is measured after introducing a DSB in two allelic neoR genes 
residing on homologous chromosomes. The loss of polymorphisms between the two neoR alleles 
resulting from a CO conversion or a NCO conversion constitutes LOH. BLM-deficient cells 
exhibit 12.9% of LOH while the control cells - less than 2.5%. Interestingly, in the control 
experiment all LOH events came from NCO conversion, while in the BLM-deficient cells the 
majority came from the CO conversion.  
In Chapter 2, I showed the development of the first SDSA assay in human cells and that 
DNA helicases such as BLM and RTEL1 are important SDSA regulators. The molecular analysis 
data indicate that BLM and RTEL1, despite negatively controlling SDSA, still act as 
recombination inhibitors (a dramatic elevation of HR in helicase knockdown cells). This raises 
questions about the contribution of helicases to CO and GC regulation. This chapter is dedicated 
to the GC analysis conducted using DR-GFP assay and the development of a novel CO-GC assay 
in human cells using DR-GFP as a backbone. 
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Results 
Gene conversion regulation in human cells using DR-GFP assay 
 DR-GFP, although initially developed in the Jasin laboratory (Pierce et al., 1999) in ES 
cells, quickly became a golden standard in studying HR and was adapted for human HEK293 
and U2OS cells (Paliwal et al., 2014; Wang et al., 2011). In this assay a DSB is generated by 
introducing a source of I-SceI to cut a non-functional GFP gene (Fig. 11A). DSB can be repaired 
using a downstream template, iGFP, which will restore a functional GFP gene (Fig. 11B). The 
restoration of a functional GFP can occur via SDSA and is often interpreted as such, however it 
can also occur via dHJ dissolution or resolution with the repair template on the homologous 
chromosome. CO between the upstream GFP gene and the downstream template is also possible, 
although will not generate a functional GFP due to iGFP repair template missing the GFP 3’end 
sequence as indicated in Fig. 11B, and would lead to a deletion of the intervening sequence. The 
same rationale applies to a possible SSA repair which would not result in the restoration of the 
functional GFP gene. 
Figure 11.  DR-GFP assay design.  
(A) DR-GFP assay construct consisting of two non-functional GFP genes: upstream GFP with an I-SceI 
recognition sequence where the DSB is going to be generated; downstream iGFP that shares a homology 
to the sequence surrounding the I-SceI cut sire, but is missing both 5’ and 3’ GFP end necessary to 
constitute a functional GFP gene. (B) A product of a DSB repair with a GC outcome leading to a 
restoration of the functional GFP gene. 
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 Paliwal et al in 2014 made an attempt to find a human functional ortholog of yeast Srs2 
and tested a number of helicases using DR-GFP assay using an siRNA approach (Paliwal et al., 
2014). They revealed RECQL5 knockdown lead to a decrease in GC in both HEK293-DRGFP 
and U2OS-DRGFP cells. This function of RECQL5 was BRCA1-depedant and thus they 
proposed that RECQL5 dismantles aberrant Rad51 filaments that prevent SDSA. Surprisingly, 
RECQL5 depletion drastically reduced an elevated level of NCOs in BLM-depleted HEK293 
cells (the results for U2OS were not reported). Another candidate for Srs2 human ortholog, 
hFBH1 helicase (FBXO18), was also tested and surprisingly FBH1 depletion lead to two-fold 
increase in GCs levels, but only in U2OS cells and not HEK293.  
 To assess the function of these, and other helicases in U2OS, I performed an experiment 
utilizing siRNA knockdown of BLM, FBXO18, FANCM, RECQL5, RTEL1, and BRACA2 as a 
control (Fig 12A). As mentioned in Chapter 2, BRCA2 is necessary for RAD51 loading and 
homology search. BRCA2 depletion in U2OS-DRGFP cells leads to a three-fold decrease in GFP 
fluorescence, indicating CGs in this assay are DNA 3’-end invasion dependent. Only depleting 
FANCM helicase leads to a decrease in GC levels in U2OS. However, depleting FBXO18 and 
RTEL1 leads to a moderate but significant increase in GCs. GC increase in FBXO18 is 
consistent with the previously published results (Paliwal et al., 2014; Wang et al., 2011), and the 
increase in RTEL1 GC levels is not surprising, considering RTEL1 depletion leads to a two-fold 
increase in SDSA as well (Fig. 5A). RECQL5 depletion did not lead to a change in GCs levels, 
unlike reported before, perhaps due to differences in the experimental design or I-SceI delivery 
(viral infection vs plasmid transfection). BLM depletion leads to a high level of cell death which 
could explain why the GC levels in U2OS-DRGFP cells remained unchanged, unlike reported in 
HEK293, or it is a bone-fide difference between U2OS and HEK293 cells.   
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Figure 12.  DNA helicases regulate gene conversion levels in U2OS.  
(A) Relative GC frequency in DRGFP U2OS cells upon siRNA treatment.  X-axis: different siRNA 
treatments; Y-axis: percent of the cells exhibiting GFP fluorescence; values: averaged results of 2 
experiments with 8 data points per treatment (except BLM: 4 data points due to poor viability); error bars: 
standard deviation; BLM statistically significant using Student T test, but not Anova analysis for multiple 
comparisons. (B) Relative GC frequency in U2OS-DRGFP cells upon drug treatment.  X-axis: different 
drug treatments; Y-axis: percent of the cells exhibiting GFP fluorescence; values: averaged results of 2 
experiments with 8 data points per treatment; error bars: standard deviation. 
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 In addition to the siRNA approach, I performed an experiment with ML216; a small 
particle identified as BLM inhibitor (Nguyen and Hickson, 2013). GCs in the U2OS-DRGFP 
cells treated with ML216 are significantly reduced (Fig. 12B) but not to the same degree as they 
were in U2OS-SDSA (Fig. 9A). The exact mechanism of ML216 action and if BLM helicase is 
the only target remains unclear.  
 
 
Development of the Crossover-Gene conversion assay 
 One limitation of the DR-GFP assay is it does not allow to determine whether GCs are 
associated with COs, if they are a product of dHJ dissolution, or SDSA. The development of the 
SDSA-specific assay was described in Chapter 2. To determine which GCs are associated with 
COs and which are not, I designed a novel CO-GC assay using the same principles DR-GFP 
assay was built on (Fig. 13A). The CO-GC assay consists of a non-functional, I-SceI-interrupted 
GFP gene where the DSB is going to be generated; the repair template which is a non-functional 
iGFP gene with a 5’-end deleted; a functional mCherry gene. The iGFP gene is placed in the 
intron of the mCherry gene in the opposite orientation to the upstream GFP gene. The cells 
stably transfected with the linearized CO-GC assay construct will exhibit red fluorescence from 
the functional mCherry gene (Fig. 13A red glowing arrow). Upon introduction of the source of I-
SceI, the gap will be repaired off of a downstream iGFP gene. GC without a CO will lead to a 
restoration of the functional GFP gene and the cell will gain green fluorescence in addition to the 
red fluorescence deriving from mCherry (Fig. 13B). GC with a CO will lead to a sequence 
inversion between the two GFP genes due to their opposite orientation (Fig. 13C). Because the 
iGFP repair template is located in an intron of the mCherry gene, a CO-initiated inversion will 
cause a separation of the mCherry promoter, which is distal to the repair template, from the 
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mCherry open reading frame, which is proximal to iGFP rendering mCherry nonfunctional. The 
cells will lose red fluorescence and turn green. The positioning of the two GFP genes ensures no 
SSA repair can occur.  
  
 
Figure 13.  Human CO assay design.  
(A) Human CO assay construct consisting of: nonfunctional GFP gene (dark green arrow) interrupted by 
the I-SceI recognition sequence (the site of the DSB once the source of I-SceI is introduced; White letter 
“I” on a blue background); functional mCherry gene (pink arrow) with its promoter (pink box); iGFP 
gene (light green arrow) inserted into mCherry intron sequence in an opposite orientation to the 
nonfunctional GFP gene. The cells exhibit mCherry fluorescence only; (B) CO assay construct after the 
occurrence of a gene conversion without CO. A functional GFP gene is restored. The cells exhibit both 
GFP and mCherry fluorescence; (C) CO assay construct after a CO between 2 GFP genes. The functional 
GFP gene is restored but the inversion between the 2 GFP genes lead to a separation of the mCherry gene 
from its promoter sequence leading to mCherry disruption. The cells exhibit GFP fluorescence only.  
 
 To generate cell lines with the CO-GC assay construct, I transfected U2OS and HEK293 
cells with a linearized pCO-GC vector and used puromycyn to select stably-integrated lines. To 
induce DSBs, I infected U2OS CO-GC cells with an adenovirus expressing I-SceI (Anglana and 
Bacchetti, 1999) and HEK293 CO-GC cells with the I-SceI expressing vector (Pierce et al., 
1999). The adenovirus undergoes a lytic cycle in HEK293 cells which are used to multiply the 
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virus, therefore these cells are not suitable with the I-SceI adenovirus. I detected mCherry and 
GFP activity in U2OS (Fig. 14), and HEK293 (Fig. 15) cells by fluorescence microscopy as 
early as two days after viral infection. Furthermore, I utilized a flow cytometry approach to 
quantify the number of cells in each fraction and determined the levels of COs and GCs (Fig. 
14D).  
 
Figure 14.  CO-GC assay in human U2OS cells. 
(A-C) Fluorescent images of the U2OS cells two days after adeno-I-SceI infection. Red arrows mark the 
cells that underwent precise NHEJ/no I-SceI cutting events; Green arrows indicate cells that underwent a 
CO event; Yellow arrows mark the cells that underwent a GC event. (A) U2OS cells captured in the 
mCherry channel. (B) U2OS cells captured in the GFP channel. (C) Merged image of mCherry and GFP 
channels. (D) Flow cytometry graph with the level of GFP fluorescence on the x-axis and mCherry 
fluorescence on the y-axis. The percent of each cell population after I-SceI cutting as indicated.  
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Figure 15.  CO-GC assay in human HEK293 cells. 
Fluorescent microscopy image of the HEK293 cells two days after nucleofection with the I-SceI 
expressing plasmid. Red arrows mark the cells that underwent precise NHEJ/no I-SceI cutting 
events; Green arrows indicate cells that underwent a CO event; Yellow arrows mark the cells 
that underwent a GC event. Merged image of the cells visible in mCherry and GFP channels. 
 
BLM helicase prevents crossovers and gene conversions in U2OS 
 To assess the role of BLM in determining DSBR outcomes I utilized an siRNA approach 
and knocked down BLM helicase in U2OS CO-GC cells. BLM depletion has been shown to 
cause both: elevated levels of SCEs, a hallmark of COs (Wechsler et al., 2011), and increased 
GCs (Paliwal et al., 2014), but using different assays. The advantage of the CO-GC assay is the 
ability to investigate both of these outcomes at the same time and compare them to one another. 
BLM knockdown in U2OS CO-GC cells cause a dramatic increase in CO levels but only a 
moderate one in GCs (Fig. 16). Data interpretation beyond this point proved to be challenging 
due to the high experiment to experiment variation of the ratio between COs and GCs. 
Considering that revealing COs events requires not only a loss of the mCherry gene but also a 
sufficient mCherry protein turnover, precise quantification using a flow cytometer within a 
siRNA knockdown timeframe might require further optimization. 
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Figure 16.  BLM helicase inhibits COs and GCs in U2OS CO-GC cells.  
Relative CO and GC frequency in U2OS CO-GC assay cells upon siRNA treatment.  X-axis: different 
siRNA treatments; (A) Y-axis: percent of the cells exhibiting GFP fluorescence; values: averaged results 
of 2 experiments with 5 data points per treatment; error bars: standard deviation; significance: p=0.0008. 
(B) Y-axis: percent of the cells exhibiting GFP and mCherry fluorescence; values: averaged results of 2 
experiments with 5 data points per treatment; error bars: standard deviation; significance: p=0.0066. 
 
BLM and FANCM prevent COs independently  
Both BLM and FANCM helicases have been implicated in affecting numerous levels of 
the DSBR pathway such is D-loop disruption, SDSA regulation, prevention of CO outcomes (see 
Introduction). Because Bloom Syndrome and Fanconi Anemia patients share multiple 
phenotypes such as sensitivity to DNA damaging agents and predisposition to cancer it had been 
proposed these two helicases might act together in resolving DNA intrerstrand crosslinks or 3’-
end resection (Suhasini and Brosh, 2012; Vinciguerra and D'Andrea, 2009). To assess the 
relationship between BLM and FANCM, I depleted either one of both helicases using siRNA 
approach in U2OS CO-GC cells and measured CO and GC levels (Fig. 17). The results indicate 
that BLM and FANCM depletion has an additive effect on CO levels but not on GC levels. This 
analysis is only preliminary as the experiment was conducted once due to flow cytometer repairs 
and availability issues. 
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Figure 17.  BLM and FANCM prevent COs independently.  
Relative CO and GC frequency in U2OS CO-GC assay cells upon siRNA treatment.  X-axis: different 
siRNA treatments; (A) Y-axis: percent of the cells exhibiting GFP fluorescence; values: averaged results 
of 1 experiment with 3 data points per treatment; error bars: standard deviation. (B) Y-axis: percent of the 
cells exhibiting GFP and mCherry fluorescence; values: averaged results of 1 experiments with 3 data 
points per treatment; error bars: standard deviation. 
 
ML216 ubiquitously reduces DSBR in U2OS CO-GC cells  
 To examine the influence of Ml216, small particle identified as BLM inhibitor, on COs 
and GCs using the CO-GC assay, I introduced the drug to the cells at the same time as adeno-I-
SceI and measured cell fluorescence three days post treatment using flow cytometry (Fig. 18). 
The results indicate that ML216 inhibits both COs (two-fold reduction; Fig 18A), and GCs 
(three-fold reduction; Fig. 18B).  
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Figure 18.  ML216 ubiquitously reduces COs and GCs in U2OS cells. 
Relative CO and GC frequency in U2OS CO-GC assay cells upon ML216 treatment.  X-axis: different 
drug treatments; (A) Y-axis: percent of the cells exhibiting GFP fluorescence; values: averaged results of 
2 experiments with 6 data points per treatment; error bars: standard deviation. (B) Y-axis: percent of the 
cells exhibiting GFP and mCherry fluorescence; values: averaged results of 2 experiments with 6 data 
points per treatment; error bars: standard deviation. 
 
 
 
 
Conclusion 
 The objective of the research conducted and described in this chapter is to investigate the 
roles of DNA helicases in regulation of CO and GC outcomes during DSBR. First, I tested a 
panel of siRNAs to assess the influence of DNA helicases on GC regulation using U2OS-
DRGFP assay (Fig. 11) developed by the Jasin laboratory (Pierce et al., 1999). The DR-GFP 
assay is currently considered a golden standard in the field of DSBR and is widely utilized by the 
scientific community. To validate the assay, and confirm the functionality of the protocol, I 
depleted BRACA2 and demonstrated a three-fold decrease of GC levels as expected (Fig. 12). 
Then, I tested siRNAs targeting BLM, FANCM, FBXO18, RECQL5, and RTEL1 (Fig. 12). The 
results for FBXO18 and RECQL5 in U2OS were previously published (Paliwal et al., 2014), 
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however only FBXO18 depletion resulted in an increase of GC as previously reported; RECQL5 
depletion yielded a wild-type phenotype as opposed to a decrease in GCs. BLM depletion 
yielded an increase in GCs that reached statistical significance using a Student T test but not 
ANOVA. BLM was previously reported to inhibit GCs in HEK293 cells using the same assay 
(Paliwal et al., 2014). Interestingly, knocking down FANCM resulted in a two-fold decrease in 
GC levels, while RTEL1 depletion yielded a moderate increase in GCs. 
 Because of the DR-GFP assay’s inability to infer the origin of GCs, I designed a novel 
CO-GC assay, based on the GFP and mCherry fluorescence, which can determine whether a GC 
resulted from a CO or other type of repair. I demonstrated this assay works both in U2OS and 
HEK293 cells using fluorescence microscopy, and tested how the BLM and FANCM depletion 
influence CO/GC outcomes in this assay. BLM depletion, as predicted, leads to a three-fold 
increase in COs and 50% increase in GCs. The preliminary results for FANCM depletion alone 
and in conjunction with BLM siRNA indicate that FANCM has a similar role in CO regulation to 
BLM, and I observed a synergistic effect from depletion of both helicases. The synergistic effect 
was not present when looking at GC levels, despite how either single knockdown seem to cause 
GC elevation in this assay. 
 Lastly, I tested whether CO-GC or DR-GFP assays are compatible with a drug treatment 
protocol. To assess it, I used a ML216 - BLM inhibitor, causing a moderate but significant 
decrease in GC levels in DR-GFP assay. However, in case of the CO-GC assay, ML216 caused 
two and three fold decrease in CO and GC levels respectively indicating a high sensitivity of this 
assay. Taken together, these data indicate the novel CO-GC assay I developed is functional for 
analysis in human cells, compatible with siRNA, and drug treatment approaches. 
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Materials and Methods 
Construction of assay plasmids  
The crossover (CO) assay construct was based on DR-GFP and the intron-containing 
mCherry gene from pDN-D2irC6kwh (Addgene #44725). DR-GFP was cut with BamHI to 
isolate the iGFP fragment and restore the original 3’ GFP sequence. This was cloned into the 
mCherry intron. The entire iGFP-containing mCherry gene was then cloned into the DR-GFP 
vector cut with HindIII so that the original iGFP fragment was replaced. 
 
Generation of stably transfected cell lines  
U2OS and HEK293 cells were cultured under normal conditions (DMEM +10% FBS + 
pen/strep) for 24h till they reached 80% confluency before transfection with a CO-GC assay 
constructs using a Nucleofector™ 2b Device (Lonza #AAB-1001) and Cell Line Nucleofector® 
Kit V (Lonza #VCA-1003). One week post-transfection appropriate antibiotics were added to 
select for the cells with a stably-integrated construct. The SDSA assay construct contains a neoR 
gene; cells receiving this construct were treated with 10 ug/ml Puromycin (Sigma # P8833) for 
one week and then a single-cell clones were derived. 
 
DNA repair assay and flow cytometry 
CO-GC-U2OS of DR-GFP cells were cultured in 10 cm dishes containing 10 ml of 
DMEM medium with high glucose; Corning) until split onto 6-well plates at a concentration of 
5x104 cells per milliliter using 0.05% Trypsin 0.53% mM EDTA solution (Corning). Upon 
reaching ~60% confluency, the cell were treated with an siRNA reaction mixture (90 nmol of 
siRNA and 8 μl lipofectamine 2000 reagent per well; Invitrogen). 24 hours after transfection the 
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siRNA reaction mixture was replaced with the fresh culture medium. 12 hours later the cells 
were treated with 100 μl of I-SceI-expressing adenovirus (Anglana and Bacchetti, 1999) 
(previously titrated to a non-lethal concentration); or transfected with an I-SceI-expressing vector 
(Jasin laboratory) using lipofectamine 2000. After another 24 hours the medium was replaced 
and thus the adenovirus removed. 72 hours later the cells were harvested and resuspended in 1x 
PBS (Corning) supplemented with 2% fetal bovine serum (FBS) and 5 mM EDTA for flow 
cytometry acquisition on a BD Aria sorter, using 488nm and 561nm lasers to detect the mCherry 
and GFP fluorescence. 
 
Genomic DNA isolation 
CO-GC U2OS cells were cultured in a 15 cm dish till they reached 100% confluency. 
Then they were rinsed gently with 1x PBS and harvested using 0.05% Trypsin 0.53 mM EDTA 
and pelleted by centrifuging for three minutes at 2000 rpm. Cells were washed with PBS and 
transferred to 1.5ml microfuge tubes and spun for 10 sec to re-pellet. PBS was removed and cells 
were resuspended in TSM + 0.5%NP-40 solution (140 mM NaCl; 10 mM Tris-HCl, pH 7.4; 1.5 
mM MgCl2), then incubated on ice for 2-3 minutes. After pelleting, cells were resuspended in 1 
ml nuclei dropping buffer (0.075 M NaCl; 0.024 M EDTA, pH 8.0). The suspension was 
transferred to a 15 ml tubes containing 4 ml of nuclei dropping buffer with 1mg of Proteinase K 
(final Proteinase K concentration = 0.2 mg/ml), and 0.5% of SDS. The cells were lysed overnight 
at 37°C. The next day an equal volume of phenol was added to lysed nuclei and mixed on an 
orbital shaker for two hours followed by a five minute spin at 2000 rpm. The aqueous phase was 
transferred to a clean tube and an equal volume of chloroform was added and the mix was 
incubated for 30 mins on an orbital shaker. After spinning, the aqueous phase was transferred to 
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a new tube and 0.1 volumes of 3M sodium acetate was added, followed by one volume of 
isopropanol. The DNA was spooled out using a glass Pasteur pipette and resuspended overnight 
in 1 ml TE buffer (10 mM Tris-HCl, pH 8.0; 1 mM EDTA, pH 8.0). The next day the DNA was 
precipitated using 0.5 volumes of 7.5M NH4OAc and two volumes of ethanol. DNA was spooled 
out and resuspended in 0.5ml TE-4 buffer (10mM Tris-HCl, pH 8.0; 0.1mM EDTA, pH 8.0). 
Samples were stored in 4°C until analyzed. 
 
Statistical data analysis 
 GraphPad Prism 6 software (version 6.07) was utilized to generate the figures presenting 
the flow cytometry results of the CO-GC and DR-GFP assays. Prism also provides a statistical 
data analysis platform. The data was analyzed using two statistical tests; one-way ANOVA with 
a correction for multiple comparisons or Student T test if a single comparison was needed. 
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1 
CHAPTER 4 
DISCUSSION AND FUTURE DIRECTIONS 
 
The primary objective of this dissertation is to genetically and molecularly characterize 
the contribution of DNA helicases to genome stability in humans. Alterations in the genetic 
material are a primary cause of cell lethality and cancer development, thus studying the 
mechanisms that ensure fidelity and efficacy during DSBR is vital. This dissertation addresses 
specifically DNA double-strand break repair via homologous recombination and focuses on 
developing novel tools necessary to study DSBR outcomes in human cells.  
 
Overview of major findings 
 I was prompt to conduct the research presented in this dissertation to bridge the gap in 
knowledge between the DSBR studies conducted in humans and in model organisms.  Since the 
proposal of the DSBR model by Szostak et al based on their work in Saccharomycetes cerevisiae 
(Szostak et al., 1983), both yeast and fruit flies have been instrumental tools in expanding our 
understanding of the mechanisms governing DNA repair. The canonical DSBR model predicts 
formation of a D-loop upon 3’-end resection, followed by DNA synthesis, and the formation and 
subsequent resolution of the dHJ intermediate (Fig. 1A-E). dHR resolution leads to a formation 
of COs and NCOs (Fig1E), however, Allers and Lichten demonstrated in yeast, that NCOs are 
generated much earlier than COs, indicating other NCO sources (Allers and Lichten, 2001). 
Since then, we learned a great deal about DNA helicases, such as Sgs1/BLM, which can either 
facilitate dHJ dissolution to prevent CO formation (Fig. 1D’)(Singh et al., 2008; Wu and 
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Hickson, 2003, 2006), or disrupt D-loops to prevent dHJ formation (Fig. 1C’) (Bachrati et al., 
2006; Youds et al., 2010). Gloor and Nassif described SDSA as one of the sources of NCOs in 
fruit flies (Gloor et al., 1991; Nassif et al., 1994). Development of SDSA assays in S. cerevisiae 
and Drosophila deepened our understanding of this process and lead to a discovery of Srs2 
(yeast) and BLM and FANCM helicases (fruit fly) as major SDSA regulators (Kuo et al., 2014) 
(Adams et al., 2003; Miura et al., 2012). Today, SDSA is thought as a predominant pathway of 
DSBR in mitotically dividing cells leading to NCOs and preventing recombination. Furthermore, 
with the recent development of CRISPR/Cas9 technology (Cong et al., 2013; Mali et al., 2013), 
replacement of multi-kilobase fragments after Cas9 cleavage has been suggested to occur 
through SDSA (Byrne et al., 2015). Paradoxically SDSA, although implied, has never been 
demonstrated in humans, because unlike in yeast or fruit flies, there are no assays to study SDSA 
in human cells.  
 In Chapter 2, I am presenting the design, describing the development, and highlighting 
the initial results from the utilization of the first human SDSA assay in U2OS (Fig. 2) (Ponten 
and Saksela, 1967) and HeLa cells (Fig. 10) (Scherer et al., 1953). Conceptually, the SDSA 
assay for human cells is similar to the P{wa} SDSA assay utilized in the Sekelsky laboratory 
(Adams et al., 2003) and consists of two non-functional mCherry genes. The upstream mCherry 
contains 18-bp I-SceI recognition sequence replacing internal 350-bp of the original sequence; 
the downstream mCherry gene consists of two mCherry fragments overlapping by the 350-bp 
sequence, but separated by a 3-kb spacer DNA. Only SDSA, with DNA synthesis reaching at 
least 350-bp, leads to the restoration of the functional mCherry gene making the assay suitable 
for both, fluorescent microscopy (Fig. 2) and flow cytometry analysis (Fig. 4). Sorting and 
clonal expansion of the repair events has also proven to be feasible and allowed initial molecular 
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characterization of the events that underwent SDSA (up to 3%) or failed to do so (Fig. 3). 
Furthermore, I validated my assays by depleting BRCA2, a protein necessary for RAD51-
mediated strand invasion and homology search, and detected a pronounced decrease in SDSA 
frequency as expected (Fig. 5). These results demonstrate convincingly that as previously 
hypothesized, human cells, along with yeast and fruit fly cells, utilize SDSA to repair DSBs 
(Adams et al., 2003; Miura et al., 2012). Nevertheless, SDSA levels up to 3% in human cells, 
although consistent with the results derived from yeast (4.7%; Miura et al., 2012) and fruit flies 
(3.8%; Adams et al., 2003), may question SDSA being a predominant pathway generating NCOs 
in eukaryotic cells. One explanation for detection of such low levels of SDSA could be the 
design of the assays. To visualize SDSA, all of the aforementioned assays rely on the ability of 
both 3’ ends to participate in the homology search and DNA invasion (Fig. 2C), effectively 
detecting only two-ended SDSA. As depicted in the DSBR model (Fig. 1C and 1C’), one-ended 
SDSA is possible, and perhaps more frequent than two-ended SDSA, but challenging to detect as 
yields outcomes indistinguishable from other NCOs (compare DNA synthesis tract patterns in 
Fig 1C’ with Fig. 1D’and 1E’). Furthermore, cell cycle profiling (Fig. 8) indicates that less than 
50% of cells reside in S-phase, when HR is promoted (Mao et al., 2008), at the time of DSB 
generation and repair (see Fig. 8C table; Day 3). Although the human SDSA assay construct 
encompasses the repair template and does not rely, unlike the P{wa} SDSA, on the presence of a 
sister chromatid, HR (and thus SDSA) in G1 (also in G2/M) is downregulated (Mao et al., 2008), 
which can contribute to lowering the numbers of mCherry positive cells.  
Despite limitations, equipped with such a powerful tool such as the first SDSA assay in 
human cells, I proceeded to the characterization of selected human DNA helicases. I focused on 
the helicases that have been either previously reported to influence SDSA in other organisms 
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(BLM, FANCM), implicated in DSBR using other assays (RECQL5, FBXO18, WRN), or shown 
to disrupt D-loops in vitro (RTEL1) (Fig. 5). I initially hypothesized, based on the results from 
the SDSA assay in Drosophila (Adams et al., 2003), that BLM and FANCM depletion will lead 
to a decrease in SDSA frequency. Only the BLM and RTEL1 siRNA knockdown yielded a 
phenotype different than the one of the non-targeting siRNA control. Surprisingly however, it 
was a two-fold increase in SDSA rather than a hypothesized decrease. SDSA increase was DNA 
3’end invasion and the homology search dependent, as knocking down BRCA2 in conjunction 
with BLM or RTEL1 resulted in a decrease of SDSA in comparison to the BLM and RTEL1 
single knockdowns (Fig. 6). This remarkable result answered the major question concerning 
which helicases regulate SDSA in human cells, but lead me to attempt to address a few others; 
what is the mechanisms of CO prevention in mitotically dividing human cells? Is SDSA a part of 
it and if so, is SDSA regulated differently in human cells than in yeast and flies?  
First, to gain insights into the mechanism of SDSA in human cells, I isolated 55 mCherry 
positive single-cell derived clones from various siRNA treatments, and utilized a PCR 
amplification approach with multiple primer sets (Table 2) to analyze them. Molecular analysis 
indicated that all of the events underwent SDSA leading to the restoration of mCherry. One event 
was missing the sequence intervening two mCherry genes indicating that SDSA was initiated, 
but then completed by the canonical DSBR with a dHJ intermediate. This result indicates the 
primary objective of the cell is to repair DNA lesions and under any circumstances allow the 
DSBs to prevail longer than necessary; the pathway choice comes second. The transition from 
SDSA to CO in this assay requires a D-loop disruption and 3’end dissociation from the proximal 
mCherry repeat with a subsequent invasion of the distal repeat, supporting the idea of a multiple 
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strand invasion mechanism previously indicated to be present in fruit flies (McVey et al., 2004b) 
and yeast (Pâques et al., 1998).       
Then, I proceeded to isolate and analyze the DNA sequence from over 200 clones that did 
not restore the mCherry gene (Fig. 7). All of the clones derived from the non-targeting siRNA 
control, and most from siBLM and siRTEL1 exhibited DNA sequence patterns consistent with 
precise NHEJ or a lack of I-SceI cutting. The remaining clones, which were derived from the 
cells depleted of BLM or RTEL1 helicases, exhibited DNA sequence patterns consistent with 
either long-tract SDSA synthesis, dHJ resolution or dissolution, or initiated SDSA but completed 
using TMEJ. These finding were consisted with a proposed anti-crossover role of BLM and 
RTEL1 helicases (Barber et al., 2008; Chaganti et al., 1974; Wechsler et al., 2011), and indicate 
that human cells depleted of BLM or RTEL1 exhibit a dramatic increase in HR.  
Because the anti-crossover role for BLM and other helicases is thought to be associated 
with their pro-SDSA role, which is supported by the findings derived from the studies in model 
organisms, it is perplexing how human BLM and RTEL1 can inhibit both COs and SDSA 
events. The molecular analysis of the repair events that failed to produce a functional mCherry 
gene in the SDSA assay revealed that the synthesis tracts were longer in the helicase depleted 
backgrounds. Synthesis tracts are also elongated in other DNA repair protein depleted 
backgrounds like BRCA1 and CtIP (Chandramouly et al., 2013). This result indicates perhaps 
350-bp synthesis, required on both sides of the break, was challenging under normal conditions 
because of BLM and RTEL1 constantly disrupting D-loop extension. Conversely, the synthesis 
proceeded uninterrupted when either BLM or RTEL1 were depleted. Considering the vast 
majority of the DNA repair studies is conducted in either U2OS or HeLa, which are cancer cell 
lines established in 1967 and 1953 respectively, it is conceivable to think that their DNA repair 
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regulation is different than in normal human cells, or perhaps years of culturing lead to 
chromosome amplifications and a copy number increase of BLM and RTEL1 genes. Should BLM 
and RTEL1 be overexpressed or hyperactive in U2OS leading to a premature D-loops disruption 
and SDSA inhibition, paradoxically, depleting these helicases in cancer cells could lead to the 
restoration of the physiological levels of SDSA presumably present in normal cells. Addressing 
these questions, although extremely interesting, would require developing an SDSA assay in 
normal cells, such as fibroblasts, and thus is beyond the scope of this work.  
 The levels of HR in human cells are currently assessed in the field of DNA repair using 
DR-GFP assay developed in the Jasin laboratory (Fig. 11) (Pierce et al., 1999). Although this GC 
assay is designed to measure all NCOs regardless of the source, some authors mistakenly 
attribute it also the ability to measure SDSA (Paliwal et al., 2014; Wang et al., 2011). I dedicated 
the first portion of Chapter 3 to the studies of GCs in different genetic backgrounds using DR-
GFP assay in U2OS (Fig. 12). I utilized an siRNA approach to deplete BRCA2 (positive control) 
and five DNA helicases: BLM, FANCM, FBXO18, RECQL5, and RTEL1. Knockdown of 
FANCM lead to a decrease in the levels GCs, while depletion of FBXO18 or RTEL1 lead to a 
moderate but significant increase in GCs. GC levels were elevated in BLM deficient background 
but did not reach statistical significance unlike previously reported in HEK293 cells (Paliwal et 
al., 2014; Wang et al., 2011). These results indicate the repair event’s origin detected in the DR-
GFP assay is at least partially different from the one in the SDSA assay. Specifically, FANCM 
seems to be required for NCO formation (Fig. 12), but not for SDSA (Fig. 5). Conversely, 
FBXO18 appears to inhibit NCOs in DR-GFP assay (Fig. 12), but does not influence SDSA 
(Fig. 5). Lastly, BLM and RTEL1 have a mild effect, if any, on GCs in general with this assay 
(Fig. 12) but when depleted lead to a two-fold increase in SDSA (Fig. 5). 
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 To address the role of human DNA helicases in preventing COs and regulating GCs, I 
designed a novel CO-GC assay for human cells (Fig. 13). This assay is conceptually similar to 
the DR-GFP assay and contains the non-functional I-SceI-interrupted GFP gene, however, there 
are major differences in its design. The repair template is a 5’end deleted GFP gene (5’ and 3’ 
deleted iGFP in DR-GFP assay) placed in an intron of a functional mCherry gene, but in the 
opposite orientation to the upstream GFP. The unique design of the CO-GC assay allows 
tracking CGs and COs using fluorescence (GFP+mCherry+ vs. GFP+ respectively) and prevents 
SSA occurrence. The assay is functional in U2OS (Fig. 14) and HEK293 cells (Fig. 15) as 
predicted, however, HEK293 cells are not compatible with the viral I-SceI delivery approach and 
exhibit high levels of spontaneous GCs. BLM helicase depletion in CO-GC U2OS cells leads to 
the elevation of CO levels which is consisted with increased SCEs observed in Bloom Syndrome 
patients (Chaganti et al., 1974; Wechsler et al., 2011), but also leads to the elevation of GCs 
which was reported before (Paliwal et al., 2014; Wang et al., 2011), and should they come from 
SDSA, these results would also be consistent with the increased SDSA levels observed in U2OS 
SDSA assay (Fig. 5).  
 Both of the assays I developed, SDSA and CO-GC, as well as the DR-GFP assay, are not 
only compatible with the siRNA approach, but also with various drug treatments. In this study, I 
used a small particle ML216, found in a screen for BLM inhibitors, as an example (Nguyen and 
Hickson, 2013). ML216 was documented to inhibit BLM DNA unwinding activity in vitro and 
partially recapitulate the increased SCEs phenotype characteristic to Bloom Syndrome patient 
cells (Nguyen and Hickson, 2013). I hypothesized, exposing U2OS-SDSA cells to ML216 will 
result in a phenotype similar to the one of BLM depletion using siRNA. Surprisingly, the BLM 
inhibitor led to a two-fold decrease in SDSA levels, rather than a two-fold increase observed in 
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BLM knockdown (Fig. 9). Further analysis using a combined siRNA and drug treatment 
approach revealed ML216 inhibits SDSA even in a BLM deficient background (Fig. 9) 
indicating ML216 might have other than BLM targets promoting SDSA. Another possible 
explanation is the levels of BLM and thus SDSA are tightly regulated in normal cells. In U2OS 
however, should the BLM helicase be upregulated or overexpressed, siRNA knockdown elevates 
SDSA levels, while ML216 addition inhibits the remaining protein and reduces SDSA. 
Therefore, ML216 treatment could be mimicking a BLM knockout, or making the inactivated 
BLM sequester other proteins required to utilize SDSA. Additionally, I tested ML216 using DR-
GFP and CO-GC assays, and discovered a pronounced decrease in CO and GC levels, suggesting 
ML216 targets a protein responsible for the regulation of all DSBR outcomes or that inactivated 
BLM is poisoning HR altogether (Fig. 12 and Fig. 18).    
 
Proposed model for the role of DNA helicases in DNA repair  
 Taken together these data strongly indicate BLM and RTEL1 helicases are major 
regulators of DNA DSB repair in human cells. BLM and RTEL1 prevent-long tract DNA 
synthesis presumably by disrupting D-loops (Fig. 19A). When either BLM or RTEL1 are 
depleted, long tract synthesis can occur which allows to synthesize 350-bp long mCherry 
fragment required to complete SDSA (Fig. 19B), but also facilitates a formation of long D-loops 
which then can be:  
1) disrupted by less processive helicases, perhaps FANCM, leading to long-SDSA (Fig. 19C);  
2) cleaved by resolvases leading to aborted SDSA, perhaps completed by TMEJ (Fig. 19D);  
3) dHJ formation and increased CO levels as seen in CO-GC and SDSA assays (Fig. 19E).  
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Figure 19.  A model for the role of DNA helicases in DNA DSB repair.  
(A) BLM and RTEL1 allow short-tract synthesis but prevent long-long tract synthesis by disrupting D-
loops; (B) In BLM or RTEL1 deficient background, uninterrupted DNA synthesis of approximately 350 
bp facilitates SDSA; (C) Long D-loops are eventually disrupted, perhaps by FANCM or another 
remaining helicase, which leads to the formation of long SDSA products encompassing the spacer DNA, 
thus rendering mCherry gene non-functional. (D) Aborted SDSA is completed my TMEJ; (E) Second-end 
capture by the long D-loop leads to a dHJ formation. This intermediate is then cleaved dHJ resolvases, 
which generate COs.  
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An alternative hypothesis could be how BLM and RTEL1 affect the cell cycle, and either 
depletion leads to an elongation of S-phase where HR was shown to be preferred over NHEJ 
(Mao, 2008). However, this is unlikely as I investigated the cell cycle profiles for three days after 
BLM depletion and did not observe any significant increase in the number of S-phase cells  
(Fig. 8) 
  
Figure 20.  BLM and RTEL1 alteration frequency in various cancer types. 
A cBioPortal-generated graph representing BLM or RTEL1 alteration frequency in any given type of 
cancer as indicated; Neuroendocrine Prostate Cancer (NEPC); Cancer Cell Line Encyclopedia (CCLE); 
The US National Cancer Institute (NCI) 60 human tumor cell line anticancer drug screen; Uterine 
Carcinosarcoma (ucs); source: www.cbioportal.org 
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Interestingly, a compilation of multiple cancer studies (Fig. 20) indicate either BLM or 
RTEL1 are mutated in 50% of breast cancer cases (for comparison, BRCA1 or BRCA2 are 
mutated in only 24%) and many other like pancreas, stomach, ovarian, and uterine cancers (20-
28% of cases). Surprisingly, the vast majority of these alterations are amplifications indicating 
multiple copies of BLM and RTEL1 may have a negative effect on preservation of genome 
stability, perhaps by premature D-loop disruption and a complete suppression of SDSA, which 
would be consistent with the increase levels of SDSA upon helicase depletion. 
 
Future Directions 
 The objective of this dissertation was to assess the role of DNA helicases in 
genome stability, especially in the contest of SDSA, GC and CO regulation. While, the work I 
conducted addresses the main question of which preselected helicases contribute to the 
aforementioned DNA repair outcomes and hints on the possible mechanism, there are other 
fascinating questions deriving from this research. 
Testing DNA helicases which are thought to disrupt D-loops or have been found to 
influence SDSA in other organisms was only the beginning. There are other candidate helicases 
to analyze their contribution to DSB repair outcomes using SDSA and CO-GC assays. Recently, 
MCM8 and MCM9 have been found to influence gametogenesis and homologous recombination 
in mice (Lutzmann et al., 2012), as well as to promote DNA resection of the MRN complex 
(Mre11- Rad50-NBS1) and thus influence the choice between NHEJ and HR (Lee et al., 2015). 
Irc20 is a poorly characterized putative DNA helicase that came out from the yeast studies, next 
to Srs2, as a positive SDSA regulator (Miura et al., 2012); finding and testing Irc20 human 
ortholog could benefit our understanding of SDSA regulation in human cells.   
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Molecular analysis of the BLM and RTEL1 deficient cells using the SDSA assay 
revealed that the repair events exhibit long-tract synthesis (Fig. 7). Long-tract synthesis has been 
observed to occur in BRCA1 and CtIP deficient cells using a GC assay developed by the Scully 
laboratory (Chandramouly et al., 2013) making these two proteins good candidates for SDSA 
regulation. Furthermore, CtIP-BRCA1 complex modulates the choice of DSB repair pathway 
throughout the cell cycle and CtIP-BRCA1 interaction is necessary not only to promote HR 
during S-phase but also to promote microhomology-mediated end-joining (MMEJ) in G1 (Yun 
and Hiom, 2009).  
Ten single-cell derived clones of the SDSA assay repair events, that occurred in BLM or 
RTEL1 depleted cells, exhibited a repair pattern consistent with initiated SDSA but completed 
by another form of end-joining, called theta-mediated end-joining (TMEJ). Polymerase theta, 
which has been found essential for TMEJ (Wyatt et al., 2016), contains a putative helicase 
domain. Its role outside TMEJ is purely speculative but could be tested using SDSA and CO-GC 
assays.  
While the Sekelsky laboratory utilizes the Drosophila SDSA assay to study helicases, 
McVey laboratory focuses on translesion synthesis (TLS) polymerases, which a number of was 
shown to be necessary for SDSA in fruit flies (Kane et al., 2012). Polymerases zeta and REV1 
were shown to promote GCs in DR-GFP HeLa cells (Sharma and Canman, 2012), yet their role 
in SDSA remains to be elucidated. McVey et al also showed there are multiple cycles of strand 
invasion during double-strand gap repair in Drosophila (McVey et al., 2004b). Although the 
SDSA assay in its current design cannot adequately assess whether it also be true for human 
cells, after introducing a number of single nucleotide polymorphisms (SNPs) to the repair 
template mCherry gene this assessment would be feasible.  
    
 
67
The search for genes regulating the SDSA or CO/GC outcomes is not limited to DNA 
helicases or TLS polymerases. UNC offers services of the RNAi HTS Facility that manages a 
human genomic siRNA library from Dharmacon, composed of ~84,500 siRNAs targeting 21,125 
genes (Ref Seq database v5.0-8.0), which presents a compelling alternative to the 
aforementioned candidate gene approaches.    
With the recent development of CRISPR/Cas9 technology of genome editing (Cong et 
al., 2013; Mali et al., 2013), one idea would be to introduce DSBs at the I-SceI recognition 
sequence using Cas9 instead of I-SceI. I-SceI cleavage leaves 4 nt 3’ overhangs while Cas9 
generates blunt ends. Both types of DSBs could be processed differently and thus lead to 
different repair outcomes. The pathway choice analysis, using both SDSA and CO-GC assays, 
would be of great importance in light of recent studies suggesting the replacement of multi-
kilobase fragments after Cas9 cleavage occurs through SDSA (Byrne et al., 2015). Additionally, 
Cas9 can be utilized to deliver DSBs at various locations of the repair assay constructs, which 
would allow assessing the minimal homologous sequence length necessary to support BRCA2-
RAD51-mediated strand invasion and homology search.  
Finally, the CRISPR/Cas9 system can be utilized to knockout or knock-in a helicase of 
interest. The major criticism of utilizing siRNA approaches to study gene functions is the 
inability to observe the phenotype exhibited by the cells devoid of studied protein. The 
CRISPR/Cas9 approach can bypass this issue, however it works best in the cell lines which, 
unlike U2OS or HeLa, are strictly haploid or diploid, and thus possess a mere one or two copies 
of the to-be-removed gene. Considering the majority of DNA helicase genes, BLM and RTEL1 
being a perfect example, is amplified in cancer cells (Fig. 20), helicase overexpression or 
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CRISPR/Cas9 knock-in can lead to further understanding of SDSA, GC, and CO regulation in 
cancer, and ultimately to a helicase-targeted drug treatment therapy.   
SDSA and CO-GC assays are fully compatible with drug treatment approaches as 
demonstrated in this dissertation using ML216 as an example (Fig. 9 and Fig. 18). In fact, the 
BLM inhibitor results proved to be most intriguing, as the dramatically decreased SDSA 
phenotype prevails even when BLM helicase is depleted. Because ML216 is a DNA mimetic 
(Nguyen et al 2013), it is conceivable to hypothesize other than BLM targets in the cell. Finding 
these targets could be the key to understanding DSB repair regulation in human cells. 
 
Conclusion 
 In conclusion, understanding the roles of the players involved in genome stability in 
humans, DNA helicases included, is of great interest for scientific community given the most 
recent Nobel prize was awarded for advancements in the field of DNA double-strand break 
repair in human cells. The original work presented in this dissertation concerning human DNA 
helicases is a small but significant contribution to this field. The tools developed while 
conducting this work, namely SDSA and CO-GC assays, offer a virtually limitless potential for 
improving our comprehension of the mechanisms that guard human genome.     
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